<SEC-DOCUMENT>0001628908-25-000010.txt : 20250204
<SEC-HEADER>0001628908-25-000010.hdr.sgml : 20250204
<ACCEPTANCE-DATETIME>20250204070130
ACCESSION NUMBER:		0001628908-25-000010
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250203
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250204
DATE AS OF CHANGE:		20250204

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Evolent Health, Inc.
		CENTRAL INDEX KEY:			0001628908
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT SERVICES [8741]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				320454912
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37415
		FILM NUMBER:		25585268

	BUSINESS ADDRESS:	
		STREET 1:		1812 NORTH MOORE ST, SUITE 1705
		CITY:			ARLINGTON
		STATE:			VA
		ZIP:			22209
		BUSINESS PHONE:		571-389-6000

	MAIL ADDRESS:	
		STREET 1:		1812 NORTH MOORE ST, SUITE 1705
		CITY:			ARLINGTON
		STATE:			VA
		ZIP:			22209
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>evh-20250203.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:dafe9667-b439-427c-95c8-7ae590833bc7,g:ffe81467-a892-473b-b900-eb8e6518a3c9,d:9fe8aeebc3fe4111b912e07e390b983e-->
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>evh-20250203</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-22">February 3, 2025</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-23">0001628908</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-24">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="evh-20250203.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001628908</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-03</xbrli:startDate><xbrli:endDate>2025-02-03</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i9fe8aeebc3fe4111b912e07e390b983e_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">_________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">_________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to Section 13 OR 15(d) of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Securities Exchange Act of 1934 </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">February 3, 2025</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported)  &#160;&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Evolent Health, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">_________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.666%"><tr><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.670%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.670%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.906%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.670%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.906%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.670%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.906%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.486%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-37415</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">32-0454912</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commission File Number:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">1812 N. Moore Street</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Suite 1705</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Arlington</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-10">Virginia</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">22209</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)(zip code)</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">571</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">389-6000</ix:nonNumeric>  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report.)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_________________________</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric>  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric>  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric>  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric>  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:31.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.770%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Class A Common Stock of Evolent Health, Inc., par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">EVH</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Emerging growth company <ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-21">&#9744;</ix:nonNumeric> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9fe8aeebc3fe4111b912e07e390b983e_72"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 1.01&#160;&#160;&#160;&#160;Entry into a Material Definitive Agreement</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 3, 2025, Evolent Health, Inc. (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) entered into a Cooperation Agreement (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Cooperation Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) with Engaged Capital, LLC and certain of its affiliates (collectively, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Engaged Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to the Cooperation Agreement, the board of directors of the Company (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Board</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) agreed, subject to the terms and conditions set forth in the Cooperation Agreement, to (1) appoint Mr. Brendan Springstubb to the Board with a term expiring at the Company&#8217;s 2025 annual meeting of stockholders (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">2025 Annual Meeting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) and (2) appoint Mr. Springstubb to (A) the Strategy Committee of the Board, effective immediately, and (B) either the Audit Committee of the Board or the Compensation Committee of the Board, as shall be agreed by the Board and Mr. Springstubb no later than the 2025 Annual Meeting. The Board also agreed to nominate Mr. Springstubb for election to the Board at the 2025 Annual Meeting. Further, if Mr. Springstubb resigns or is unable to serve on the Board during the term of the Cooperation Agreement, so long as Engaged Capital holds 3% or more of the Company&#8217;s outstanding Class A common stock, excluding notional shares associated with derivatives, Engaged Capital will be entitled to recommend his replacement, subject to the Board&#8217;s review and approval of such candidate (which approval may not be unreasonably withheld). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Cooperation Agreement further provides, among other things, that: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:32.5pt">During the term of the Cooperation Agreement, Engaged Capital will be subject to customary standstill restrictions, including with respect to acquiring beneficial ownership (including notional shares associated with derivatives) in the aggregate of more than 9.9% of the Company&#8217;s Class A common stock, nominating or recommending for nomination any persons for election to the Board (except as expressly permitted by the Cooperation Agreement), submitting any proposal for consideration at any stockholder meeting and soliciting any proxy, consent or other authority to vote from stockholders or conducting any other referendum (including any &#8220;withhold,&#8221; &#8220;vote no&#8221; or similar campaign). </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:32.5pt">During the term of the Cooperation Agreement, Engaged Capital will vote all of its shares of the Company&#8217;s Class A common stock at all annual and special meetings as well as in any consent solicitations of the Company&#8217;s stockholders (1) in favor of the slate of directors recommended by the Board, against or withhold from voting in favor of the election of any director nominee not approved, recommended and nominated by the Board for election and against any removal of any director of the Board and (2) in accordance with the Board&#8217;s recommendation for any other matter (unless Institutional Shareholder Services Inc. or Glass Lewis &amp; Co., LLC issues a contrary recommendation); provided that Engaged Capital will be permitted to vote on any proposals relating to an &#8220;Extraordinary Transaction&#8221; (defined in the Cooperation Agreement to include certain change of control transactions or the sale of substantially all of the Company&#8217;s assets) in its sole discretion. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:32.5pt">Each party agrees to a certain mutual non-disparagement provision.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:32.5pt">Each party agrees not to institute any lawsuit against the other party, subject to certain exceptions including the seeking of remedies for a breach of the Cooperation Agreement. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:32.5pt">The Cooperation Agreement will terminate on the earliest to occur of (1) 30 days prior to the director nomination notice deadline for the 2026 annual meeting of the Company&#8217;s stockholders, (2) 30 days prior to the first anniversary of the director nomination notice deadline for the 2025 Annual Meeting and (3) the closing of an Extraordinary Transaction. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The summary above is qualified in its entirety by reference to the full text of the Cooperation Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference. </span></div><div><span><br/></span></div><div id="i9fe8aeebc3fe4111b912e07e390b983e_79"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 5.02 &#160;&#160;&#160;&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Resignation of M. Bridget Duffy, MD</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 3, 2025, M. Bridget Duffy, MD resigned from the Board. Dr. Duffy&#8217;s decision to resign was not the result of any disagreement between the Company and Dr. Duffy on any matter relating to the Company&#8217;s operations, policies, or practices. Dr. Duffy had previously considered whether to stand for re-election to the Board at the 2025 Annual Meeting, and, after discussion with the Board, elected to resign in advance of the 2025 Annual Meeting in order to create a vacancy at an earlier date. In connection with Dr. Duffy&#8217;s resignation, the Board accelerated the vesting of 7,709 restricted stock units granted under the Company&#8217;s 2015 Omnibus Incentive Compensation Plan that were previously scheduled to vest upon the earlier of June 6, 2025 and the 2025 Annual Meeting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Appointment of Brendan Springstubb</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to the Cooperation Agreement described above in Item 1.01, on February 4, 2025, the Board (1) appointed Mr. Springstubb as a director with a term expiring at the 2025 Annual Meeting and (2) appointed Mr. Springstubb to the Strategy Committee of the Board. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mr. Springstubb was previously an employee of Engaged Capital and, until January 31, 2025, provided consulting services to Engaged Capital in connection with its investment in the Company and another publicly-traded healthcare company. As compensation for such services, Mr. Springstubb remains entitled to potential future contingent payments from Engaged Capital based on Engaged Capital&#8217;s investment in the Company, consisting of (A) a success fee based on certain profits earned by Engaged Capital&#8217;s clients since January 1, 2023 in relation to investment in the Company through full disposition of such investment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> the total losses incurred by Engaged Capital&#8217;s clients in connection with its investments in both the Company and another publicly-traded healthcare company through full disposition of such investments and (B) a $250,000 supplemental fee payable no later than twelve months following Engaged Capital&#8217;s full disposition of its investment in the Company. Mr. Springstubb is an investor in certain funds managed by Engaged Capital that hold shares of the Company&#8217;s Class A common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Board has determined that Mr. Springstubb is an independent director in accordance with applicable New York Stock Exchange and Securities and Exchange Commission rules and regulations and the Company&#8217;s corporate governance guidelines.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mr. Springstubb will be eligible to participate in the compensation arrangements and programs that are established for the Company&#8217;s non-employee directors. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i9fe8aeebc3fe4111b912e07e390b983e_85"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Events</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 4, 2025, the Company issued a press release announcing the appointment of Mr. Springstubb to the Board, as well as plans to name Richard Jelinek as Chair of the Board at the Company&#8217;s 2025 Annual Meeting and the ongoing search process to refresh an independent director in advance of the 2025 Annual Meeting. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. </span></div><div><span><br/></span></div><div id="i9fe8aeebc3fe4111b912e07e390b983e_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 9.01 - Financial Statements and Exhibits. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) Exhibits </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:83.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="a202524exhibit101.htm">10.1</a></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="a202524exhibit101.htm">Cooperation Agreement dated February 3, 2025, by and among Evolent Health, Inc., Engaged Capital Flagship Master Fund, LP, Engaged Capital Co-Invest XI-B, LP, Engaged Capital, LLC, Engaged Capital Holdings, LLC and Glenn W. Welling.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="a202524exhibit991.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="a202524exhibit991.htm">Press Release dated February 4, 2025.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.</span></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i9fe8aeebc3fe4111b912e07e390b983e_10"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">SIGNATURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;     </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;             </span></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.75pt"><tr><td style="width:1.0pt"/><td style="width:49.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:172.75pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EVOLENT HEALTH, INC.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;/s/ Jonathan D. Weinberg</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Jonathan D. Weinberg</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">General Counsel and Secretary</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">February 4, 2025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a202524exhibit101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="idc3d654e76d0462c95f5f0d4a7fc1817_1"></div><div style="min-height:74.16pt;width:100%"><div style="margin-top:0.5pt;text-align:right"><font><br></font></div><div style="margin-top:0.5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-bottom:9pt;padding-left:34.9pt;padding-right:34.9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">COOPERATION AGREEMENT</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Cooperation Agreement, dated as of February 3, 2025 (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), is by and among Evolent Health, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and the persons and entities set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Engaged Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#8221; and, for clarity and as applicable, including each member thereof acting individually).</font></div><div style="margin-bottom:9pt;padding-left:34.9pt;padding-right:34.9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RECITALS</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company and Engaged Capital, LLC, a member of the Engaged Group, have engaged in various discussions and communications concerning the Company&#8217;s business, financial performance and strategic plans&#59;</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, as of the date hereof, the Engaged Group is the Beneficial Owner (as defined below) of 5,619,468 shares of Class A common stock, $0.01 par value per share, of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), or approximately 4.8% of the Common Stock issued and outstanding on the date hereof&#59; </font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, M. Bridget Duffy, MD has tendered her resignation from the Board of Directors of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and the Board has accepted such resignation, effective as of the date hereof&#59; and</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company and the Engaged Group have determined to come to an agreement with respect to certain matters relating to the composition of the Board and certain other matters, as provided in this Agreement.</font></div><div style="margin-bottom:9pt;padding-left:34.9pt;padding-right:34.9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AGREEMENT</font></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties (as defined below), intending to be legally bound hereby, agree as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:78pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Board Appointments, Committees and Related Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.</font></div><div style="margin-bottom:9pt;padding-left:114pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Board Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;padding-left:60pt;padding-right:9.8pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.69pt">Immediately following the execution of this Agreement, the Board and all applicable committees of the Board shall take all necessary actions to appoint Brendan B. Springstubb (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">New Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) as a director of the Board with a term expiring at the 2025 annual meeting of stockholders of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">2025 Annual Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:9pt;padding-left:60pt;padding-right:9.75pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15.36pt">The Board will include the New Director as a nominee for election to the Board on the slate of nominees recommended by the Board in the Company&#8217;s proxy statement and on its proxy card relating to the 2025 Annual Meeting and take all necessary or appropriate actions to cause the election of the New Director to the </font></div><div style="height:86.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:60pt;padding-right:9.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Board at the 2025 Annual Meeting, including&#58; (A) recommending that the Company&#8217;s stockholders vote in favor of the New Director and (B) otherwise supporting the New Director in a manner no less rigorous and favorable than the manner in which the Company supports the Board&#8217;s other nominees.</font></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.07pt;text-decoration:underline">Director Committee Appointments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Subject to the Company&#8217;s Corporate Governance Guidelines, the applicable committee&#8217;s charter, NYSE rules and applicable laws, the Board and all applicable committees of the Board shall take all actions necessary to ensure that from and after the appointment of the New Director to the Board and until the Termination Date (as defined below), the New Director is appointed to (A) the Strategy Committee of the Board, effective immediately, and (B) one of either the (1) Compensation Committee of the Board or (2) Audit Committee of the Board, as to be agreed to by the New Director and the Board following the New Director&#8217;s appointment to the Board, effective no later than the 2025 Annual Meeting. Without limiting the foregoing, the Board shall give the New Director the same due consideration for membership to any committee of the Board as any other independent director.</font></div><div style="margin-bottom:9pt;margin-top:0.05pt;padding-left:4.5pt;padding-right:9.7pt;text-align:justify;text-indent:73.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.7pt;text-decoration:underline">Replacement Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. From the date of this Agreement until the Termination Date, if the New Director is unable or unwilling to serve as a director, resigns as a director or is removed as a director, and so long as the Engaged Group continuously Beneficially Owns in the aggregate at least the lesser of (x) 3.0% of the Company&#8217;s then outstanding Common Stock and (y) 3,496,917 shares of Common Stock, in the case of each of clauses (x) and (y), excluding notional shares associated with any Derivative or other Synthetic Position (subject to adjustment for stock splits, reclassifications and combinations, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Ownership Minimum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), then the Engaged Group shall have the ability to recommend a substitute person(s) to replace the New Director in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (any such replacement director, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Replacement Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The appointment of any Replacement Director shall be subject to (A) the execution and delivery by such Replacement Director of a fully completed copy of the Company&#8217;s standard director and officer questionnaire and other reasonable and customary director onboarding documentation required by the Company in connection with the appointment or election of new Board members&#59; (B) such Replacement Director satisfying the Director Criteria (as defined below)&#59; and (C) the approval of the Board (it being acknowledged that the Board cannot unreasonably withhold its approval), taking into account the recommendation of the Nominating and Governance Committee of the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Nominating Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The Nominating Committee shall make its determination and recommendation regarding whether such candidate so qualifies within five (5) Business Days after such candidate has submitted to the Company the documentation required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1(d)(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> below. In the event the Nominating Committee does not accept a substitute person recommended by the Engaged Group as the Replacement Director (it being acknowledged that the Nominating Committee cannot unreasonably withhold its approval), the Engaged Group shall have the right to recommend additional substitute person(s) whose appointment shall be subject to the Nominating Committee recommending such person in accordance with the procedures described above. Upon the recommendation of a Replacement Director candidate by the Nominating Committee, the Board shall review, approve and vote on the appointment of such Replacement Director to the Board no later than five (5) Business Days after the Nominating Committee&#8217;s recommendation of such Replacement Director&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font></div><div style="height:86.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:0.05pt;padding-left:4.5pt;padding-right:9.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if the Board does not approve and appoint such Replacement Director to the Board (it being acknowledged that the Board cannot unreasonably withhold its approval), the Parties shall continue to follow the procedures of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> until a Replacement Director is approved and appointed to the Board. Upon a Replacement Director&#8217;s appointment to the Board, the Board and all applicable committees of the Board shall consider whether such Replacement Director has the necessary qualifications to be appointed to any committee of the Board of which the replaced director was a member immediately prior to such director&#8217;s departure from the Board, and, if the qualifications for such committee(s) are met, shall appoint such Replacement Director to such committee(s) or, if the qualifications for such committee(s) are not met, shall consider in good faith appointing the Replacement Director to other committees of the Board. Any Replacement Director designated pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> replacing the New Director prior to the 2025 Annual Meeting shall stand for election at the 2025 Annual Meeting together with the Company&#8217;s other nominees. Upon a Replacement Director&#8217;s appointment to the Board, such Replacement Director shall be deemed to be the New Director for all purposes under this Agreement.</font></div><div style="margin-bottom:9pt;padding-left:114pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Additional Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;padding-left:59.95pt;padding-right:9.85pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.74pt">The Engaged Group agrees (A) to cause its Affiliates and Associates (each as defined below) to comply with the terms of this Agreement and (B) that it shall be responsible for any breach of this Agreement by any such Affiliate or Associate. A breach of this Agreement by an Affiliate or Associate of any member of the Engaged Group, if such Affiliate or Associate is not a Party, shall be deemed to occur if such Affiliate or Associate engages in conduct that would constitute a breach of this Agreement if such Affiliate or Associate were a Party to the same extent as the Engaged Group.</font></div><div style="margin-bottom:9pt;padding-left:59.95pt;padding-right:9.65pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15.41pt">Until the Termination Date, the Engaged Group agrees that it shall, and shall cause each of its Affiliates and Associates to, appear in person or by proxy or participate virtually at each annual or special meeting of the stockholders of the Company, or any action by written consent of the Company&#8217;s stockholders in lieu thereof, and any adjournment, postponement, rescheduling or continuation thereof (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and vote all Voting Securities (as defined below) Beneficially Owned, directly or indirectly, by the Engaged Group or any such Affiliate or Associate (or which the Engaged Group or such Affiliate or Associate has the right or ability to vote) at such meeting (A) in favor of the nominees for director recommended by the Board, against or withhold from voting in favor of the election of any nominee for director not approved, recommended and nominated by the Board for election at any such meeting, and against any removal of any director of the Board, and (B) in accordance with the Board&#8217;s recommendation with respect to any other matter presented at such meeting&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in the event Institutional Shareholder Services Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ISS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or Glass Lewis &#38; Co., LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Glass Lewis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) recommends otherwise with respect to any proposals (other than the election of directors), the Engaged Group shall be permitted to vote in accordance with the ISS or Glass Lewis recommendation&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Engaged Group shall </font></div><div style="height:86.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:59.95pt;padding-right:9.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">be permitted to vote in its sole discretion with respect to any publicly announced proposals relating to an Extraordinary Transaction.</font></div><div style="margin-bottom:12pt;padding-left:60pt;padding-right:9.8pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Until the Termination Date, upon written request from the Company, the Engaged Group shall promptly provide the Company with information regarding the amount of the securities of the Company then Beneficially Owned (including notional shares associated with any Derivatives or other Synthetic Position) by the Engaged Group. Such written request may be made by the Company no more than once per month and the information provided to the Company in response shall be kept strictly confidential unless required to be disclosed pursuant to law, the rules of any stock exchange or any Legal Requirement (as defined below).</font></div><div style="margin-bottom:12pt;padding-left:60pt;padding-right:9.8pt;text-align:justify;text-indent:52.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:14.19pt">Prior to the date of this Agreement, the New Director has submitted to the Company a fully completed copy of the Company&#8217;s standard director &#38; officer questionnaire and other reasonable and customary director onboarding documentation required by the Company of all current directors in connection with the appointment or election of new Board members. Any Replacement Director will also promptly (but in any event prior to being placed on the Board in accordance with this Agreement) submit to the Company a fully completed copy of the Company&#8217;s standard director &#38; officer questionnaire and other reasonable and customary director onboarding documentation required by the Company of all current non-employee directors in connection with the appointment or election of new Board members.</font></div><div style="margin-bottom:12pt;padding-left:78pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Standstill Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.75pt">Until the Termination Date, the Engaged Group shall not, and shall cause each of its Affiliates and Associates not to, directly or indirectly, in any manner, alone or in concert with others&#58;</font></div><div style="margin-bottom:9pt;padding-left:59.95pt;padding-right:9.7pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.74pt">(A) acquire, cause to be acquired, or offer, seek or agree to acquire, whether by purchase, tender or exchange offer, through the acquisition of control of another person, by joining or forming a partnership, limited partnership, syndicate or other group (including any group of persons that would be treated as a single &#8220;person&#8221; under Section 13(d) of the Exchange Act (as defined below)), through swap or hedging transactions, other Synthetic Positions or otherwise (the taking of any such action, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), Beneficial Ownership (including notional shares associated with any Derivatives or other Synthetic Positions) of any securities or assets of the Company (or any direct or indirect rights or options to acquire such ownership, including voting rights decoupled from the underlying Voting Securities) such that after giving effect to any such Acquisition, the Engaged Group or any of its Affiliates and Associates holds, directly or indirectly, in excess of 9.9% of the Voting Securities, (B) acquire, cause to be acquired or offer, seek or agree to acquire, whether by purchase or otherwise, any interest in any indebtedness of the Company, or (C) acquire, cause to be acquired or offer, seek or agree to acquire, ownership of </font></div><div style="height:86.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:59.95pt;padding-right:9.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any asset or business of the Company or any right or option to acquire any such asset or business from any person&#59;</font></div><div style="margin-bottom:9pt;padding-left:59.95pt;padding-right:9.6pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15.41pt">(A) nominate, give notice of an intent to nominate, or recommend for nomination a person for election to the Board or take any action in respect of the removal of any director (in each case other than pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), (B) seek or knowingly encourage any person to submit any nomination in furtherance of a &#8220;contested solicitation&#8221; or take any other action in respect of the election or removal of any director (in each case other than pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), (C) submit, or seek or knowingly encourage the submission of, any stockholder proposal (pursuant to Rule 14a-8 under the Exchange Act or otherwise) for consideration at, or bring any other business before, any Stockholder Meeting, (D) request, or knowingly initiate, encourage or participate in any request, to call a Stockholder Meeting, (E) publicly seek to amend any provision of the Second Amended and Restated Certificate of Incorporation (as amended by the Certificate of Amendment thereto), Third Amended and Restated By-Laws (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">By-Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or other governing documents of the Company (each as may be amended from time to time) or (F) take any action similar to the foregoing with respect to any subsidiary of the Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that nothing in this Agreement shall prevent the Engaged Group or its Affiliates or Associates from taking actions in furtherance of identifying director candidates in connection with the 2026 annual meeting of stockholders of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">2026 Annual Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) so long as such actions do not create a public disclosure obligation for the Engaged Group or the Company and are undertaken on a basis reasonably designed to be confidential and in accordance in all material respects with the Engaged Group&#8217;s normal practices in the circumstances&#59;</font></div><div style="margin-bottom:9pt;padding-left:59.95pt;padding-right:9.6pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.08pt">solicit any proxy, consent or other authority to vote of stockholders or conduct any other referendum (binding or non-binding) (including any &#8220;withhold,&#8221; &#8220;vote no&#8221; or similar campaign) with respect to, or from the holders of, Voting Securities, or become a &#8220;participant&#8221; (as such term is defined in Instruction 3 to Item 4 of Schedule 14A promulgated under the Exchange Act) in, or knowingly assist, advise, initiate, encourage or influence any person (other than the Company) in, any &#8220;solicitation&#8221; of any proxy, consent or other authority to vote any Voting Securities (other than such assistance, advice, encouragement or influence that is consistent with the Board&#8217;s recommendation in connection with such matter)&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the foregoing shall not restrict the Engaged Group or its Affiliates or Associates from stating how they intend to vote with respect to an Extraordinary Transaction, if any, that has been publicly submitted for the approval of the Company&#8217;s stockholders and the reasons therefor&#59;</font></div><div style="margin-bottom:9pt;padding-left:59.95pt;padding-right:9.75pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.74pt">(A) grant any proxy, consent or other authority to vote with respect to any matters for any Stockholder Meeting or (B)&#8239;deposit any securities of the Company in any voting trust or subject any securities of the Company to any arrangement or agreement with respect to the voting of any such securities of the Company, in each case of clauses (A) and (B) other than (1)&#8239;customary brokerage </font></div><div style="height:86.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:59.95pt;padding-right:9.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">accounts, margin accounts, prime brokerage accounts and similar accounts (in each case so long as the Engaged Group retains control with respect to the securities deposited in such accounts), (2)&#8239;granting any proxy, consent or other authority to vote in any solicitation approved by the Board and consistent with the recommendation of the Board, and (3)&#8239;granting any proxy, consent or other authority to vote in any solicitation in connection with any matter for which the Engaged Group retains voting discretion pursuant to, and in accordance with, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1(d)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:9pt;padding-left:60pt;padding-right:9.75pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.02pt">knowingly encourage, advise or influence any person or knowingly assist any person in so encouraging, advising or influencing any person, with respect to the giving or withholding of any proxy, consent or authority to vote any Voting Securities or in conducting any referendum (binding or non-binding) (including any &#8220;withhold,&#8221; &#8220;vote no,&#8221; or similar campaign), in each case other than such encouragement, advice or influence that is consistent with the Board&#8217;s recommendation in connection with such matter or otherwise in connection with an Extraordinary Transaction that has been publicly submitted for the approval of the Company&#8217;s stockholders&#59;</font></div><div style="margin-bottom:9pt;padding-left:60pt;padding-right:9.75pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.69pt">without the prior written approval of the Company, separately or in conjunction with any other person in which it is or proposes to be either a principal, partner or financing source or is acting or proposes to act as broker or agent for compensation, propose, suggest or recommend publicly or in a manner that the Engaged Group is required under applicable law, rule or regulation to disclose publicly or participate in, effect or seek to effect any Extraordinary Transaction or knowingly encourage any other third party in any such activity&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that nothing in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2(a)(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be interpreted to prohibit the Engaged Group from (1) proposing, suggesting or recommending any Extraordinary Transaction privately to the Company so long as any such action is not publicly disclosed by the Engaged Group and is made by the Engaged Group in a manner that would not reasonably be expected to require the public disclosure thereof by the Company, the Engaged Group or any other person or (2) tendering shares, receiving consideration or other payment for shares, or otherwise participating in any publicly announced Extraordinary Transaction on the same basis as other stockholders of the Company&#59;</font></div><div style="margin-bottom:9pt;padding-left:59.95pt;padding-right:9.45pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.41pt">form, join, encourage the formation of, or in any way participate in any partnership, limited partnership, syndicate or group (within the meaning of Section 13(d)(3) of the Exchange Act) with respect to any Voting Securities (other than a group that includes all or some of the members of the Engaged Group, but does not include any other entities or persons that are not members of the Engaged Group as of the date hereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that nothing herein shall limit the ability of an Affiliate of the Engaged Group to join such group following the execution of this Agreement, so long as any such Affiliate agrees to be bound by the terms and conditions of this Agreement)&#59;</font></div><div style="height:86.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:60pt;padding-right:9.8pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:6.03pt">make or publicly advance any request or proposal to amend, modify or waive any provision of this Agreement, or take any action challenging the validity or enforceability of any provision of or obligation arising under this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the Engaged Group may make confidential requests to the Board to amend, modify or waive any provision of this Agreement, which the Board may accept or reject in its sole and absolute discretion, so long as any such request is not publicly disclosed by the Engaged Group and is made by the Engaged Group in a manner that would not reasonably be expected to require the public disclosure thereof by the Company, the Engaged Group or any other person&#59;</font></div><div style="margin-bottom:9pt;padding-left:60pt;padding-right:9.85pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.69pt">make a request for a list of the Company&#8217;s stockholders or for any books and records of the Company pursuant to Section 220 of the General Corporation Law of the State of Delaware (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">DGCL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; or</font></div><div style="margin-bottom:9pt;padding-left:60pt;padding-right:9.8pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.02pt">enter into any discussion, negotiation, agreement, arrangement or understanding concerning any of the foregoing (other than this Agreement) or encourage, assist, solicit, seek, or seek to cause any person to undertake any action inconsistent with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.02pt">Notwithstanding anything in this Agreement to the contrary, the foregoing provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall not be deemed to restrict the Engaged Group from&#58; (i) communicating privately with the Board or any of the Company&#8217;s officers regarding any matter, so long as such communications are not intended to, and would not reasonably be expected to, require any public disclosure of such communications, (ii) communicating privately with stockholders of the Company and others in a manner that does not otherwise violate this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, or (iii) taking any action necessary to comply with any Legal Requirement (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that such Legal Requirement did not result from any violation of this Agreement or other voluntary action by the Engaged Group). Furthermore, for the avoidance of doubt, nothing in this Agreement shall be deemed to restrict in any way the New Director in the exercise of the New Director&#8217;s fiduciary duties under applicable law as a director of the Company. </font></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.05pt;text-decoration:underline">Representations and Warranties of All Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Party represents and warrants to the other Party that (a) such Party has all requisite power and authority to execute and deliver this Agreement and to perform its obligations hereunder, (b) this Agreement has been duly and validly authorized, executed and delivered by it and is a valid and binding obligation of such Party, enforceable against such Party in accordance with its terms (subject to applicable bankruptcy and similar laws relating to creditors&#8217; rights and to general equity principles), and (c) this Agreement will not result in a material violation of any (i) term or condition of any agreement to which such Party is a party or by which such Party may otherwise be bound or (ii) law, rule, license, regulation, judgment, order or decree governing or affecting such Party.</font></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.05pt;text-decoration:underline">Representations, Warranties and Covenants of the Engaged Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Engaged Group represents, warrants and covenants to the Company that (a) as of the date of this Agreement, the Engaged Group collectively Beneficially Owns and is entitled to vote an </font></div><div style="height:86.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">aggregate of 5,619,468 shares of Common Stock and has economic exposure to an additional 1,362,000 shares of Common Stock in the form of certain cash-settled total return swap agreements, (b) except as set forth in the preceding clause (a), as of the date of this Agreement, the Engaged Group does not have, and does not have any right to acquire, any interest in any indebtedness or other securities of the Company, or a Synthetic Position (as defined below), (c) the Engaged Group has not provided or agreed to provide, and will not provide, any compensation in cash or otherwise to the New Director or any Replacement Director in connection with such person&#8217;s appointment to, or service as a director on, the Board, (d) the New Director is not a current employee of the Engaged Group, (e) prior to the date of this Agreement, the Engaged Group has disclosed to the Company all relationships (including compensation arrangements) between the Engaged Group and the New Director (including in his capacity as an independent consultant), (f) (1) prior to or substantially concurrently with the effectiveness of this Agreement, the Consulting Agreement entered into between members of the Engaged Group and Bedell Canyon, LLC, dated November 16, 2023, and any related agreements, arrangements or understandings between any members of the Engaged Group and the New Director (or any Affiliate of the New Director) shall have been terminated and (2) after giving effect to such termination(s), the New Director (including vis-&#224;-vis Bedell Canyon, LLC or any other Affiliate of the New Director) shall not provide any services to members of the Engaged Group with respect to the Company and shall only be entitled to the compensation from the Engaged Group as previously disclosed in the New Director&#8217;s director and officer questionnaire, and (g) the Engaged Group has not been party to, and is not and will not become party to, any agreement, arrangement or understanding (whether written or oral) with the New Director or any Replacement Director with respect to such person&#8217;s service as a director on the Board, including any such agreement, arrangement or understanding with respect to how such person should or would vote or act on any issue or question as a director.</font></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.05pt;text-decoration:underline">Non-Disparagement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Subject to applicable law, each of the Parties covenants and agrees that, until the Termination Date, or if earlier, until such time as the other Party or any of its Representatives (as defined below) shall have breached this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, neither it nor any of its Representatives shall in any way attempt to discredit, make derogatory statements with respect to, call into disrepute, defame, make or cause to be made any statement or announcement that relates to and constitutes an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">ad hominem </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">attack on, or relates to and otherwise disparages (or causes to be disparaged) the other Party or such other Party&#8217;s subsidiaries, Affiliates, successors, assigns, officers (including any current or former officer of a Party or a Parties&#8217; subsidiaries, in each case solely in connection with their service in such capacities), directors (including any current or former director of a Party or a Parties&#8217; subsidiaries, in each case solely in connection with their service in such capacities) or employees (solely in connection with their service in such capacities) (or attorneys or Representatives solely in the context of their representation of a Party in connection with the subject matter of this Agreement), or any of their practices, procedures, businesses, business operations, products or services, in any manner. The foregoing shall not prevent the making of any factual statement in connection with any compelled testimony or production of information by Legal Requirement.</font></div><div style="height:86.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:5.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.05pt;text-decoration:underline">No Litigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Party agrees that, until the Termination Date, it shall not institute, solicit, join or assist in any lawsuit, claim or proceeding before any court or government agency (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) against the other Party, any Affiliate of the other Party or any of their respective current or former directors or officers (solely in connection with their service in such capacities), except for (a) any Legal Proceeding initiated primarily to remedy a breach of or to enforce this Agreement and (b) counterclaims with respect to any proceeding initiated by or on behalf of one Party or its Affiliates against the other Party or its Affiliates&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the foregoing shall not prevent any Party or any of its Representatives from responding to oral questions, interrogatories, requests for information or documents, subpoenas, civil investigative demands or similar processes (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) in connection with any Legal Proceeding if such Legal Proceeding has not been initiated by, on behalf of or at the suggestion of such Party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in the event any Party or any of its Representatives receives such Legal Requirement, such Party shall give prompt written notice of such Legal Requirement to the other Party (except where such notice would be legally prohibited or not practicable). Each Party represents and warrants that neither it nor any assignee has filed any lawsuit against the other Party.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Engaged Group acknowledges and agrees that the New Director shall be required to preserve the confidentiality of the Company&#8217;s information, including any non-public information entrusted to or obtained by such director by reason of the New Director&#8217;s position as a director of the Company. The Engaged Group further acknowledges and agrees that the New Director shall not share any information about the Company with the Engaged Group without the Board&#8217;s consent, and the Engaged Group shall not seek to obtain any such confidential information from the New Director.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Press Release&#59; Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Promptly following the execution of this Agreement, the Company shall issue the press release in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Press Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) announcing certain terms of this Agreement and other matters. Neither the Company nor the Engaged Group shall make or cause to be made, and the Company and the Engaged Group shall cause their respective Affiliates and Associates not to make or cause to be made, any public announcement or statement with respect to the subject matter of this Agreement that is contrary to the statements made in the Press Release or the terms of this Agreement, except as required by law or the rules of any stock exchange or with the prior written consent of the other Party. The Engaged Group acknowledges and agrees that the Company may file this Agreement and file or furnish the Press Release with the SEC as exhibits to a Current Report on Form 8-K and other filings with the SEC. The Engaged Group shall be given a reasonable opportunity to review and comment on the disclosure related hereto in any Current Report on Form 8-K or other filing with the SEC made by the Company with respect to this Agreement, and the Company shall give reasonable consideration to any comments of the Engaged Group.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Party shall be responsible for its own fees and expenses incurred in connection with the negotiation, execution and effectuation of this Agreement and the transactions contemplated hereby, except that the Company shall reimburse the Engaged Group for its reasonable documented expenses, including legal fees incurred in connection with the </font></div><div style="height:86.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">negotiation and entry into this Agreement and the matters related thereto, in an amount not to exceed $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">80,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;padding-left:4.5pt;padding-right:9.8pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:12pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement shall terminate on the earliest to occur of (a) thirty (30) calendar days prior to the notice deadline under the By-Laws for the nomination of director candidates for election to the Board at the 2026 Annual Meeting, (b) thirty (30) calendar days prior to the first anniversary of the notice deadline under the By-Laws for the nomination of director candidates for election to the Board at the 2025 Annual Meeting, and (c) the closing of an Extraordinary Transaction (the effective date of termination, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). Notwithstanding the foregoing, the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall survive the termination of this Agreement. No termination of this Agreement shall relieve any Party from liability for any breach of this Agreement prior to such termination.</font></div><div style="margin-bottom:9pt;padding-left:78pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.05pt;text-decoration:underline">Certain Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. For purposes of this Agreement&#58;</font></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.75pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Rule 12b-2 promulgated by the SEC under the Exchange Act, and shall include all persons or entities that at any time during the term of this Agreement become Affiliates of any person or entity referred to in this Agreement&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"> provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that this term shall refer only to Affiliates controlled by the Company or the members of the Engaged Group, as applicable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that, for purposes of this Agreement, the members of the Engaged Group shall not be Affiliates of the Company and the Company shall not be an Affiliate of the members of the Engaged Group.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Associate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Rule 12b-2 promulgated by the SEC under the Exchange Act, and shall include all persons or entities that at any time during the term of this Agreement become Associate of any person or entity referred to in this Agreement&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"> provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that this term shall refer only to Associates controlled by the Company or the members of the Engaged Group, as applicable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that, for purposes of this Agreement, the members of the Engaged Group shall not be Associates of the Company and the Company shall not be an Associate of the members of the Engaged Group.</font></div><div style="margin-bottom:9pt;padding-left:4.5pt;padding-right:9.7pt;text-align:justify;text-indent:73.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.7pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficial Ownership</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means having the right or ability to vote, cause to be voted or control or direct the voting of any Voting Securities (in each case whether directly or indirectly, including pursuant to any agreement, arrangement or understanding, whether or not in writing)&#59; provided that a person shall be deemed to have &#8220;Beneficial Ownership&#8221; of any Voting Securities that such person has a right, option or obligation to own, acquire or control or direct the voting of upon conversion, exercise, expiration, settlement or similar event (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) under or pursuant to (i) any Derivative (as defined below) (whether such Derivative is subject to Exercise immediately or only after the passage of time or upon the satisfaction of one or more conditions) and (ii) any Synthetic Position that is required or permitted to be settled, in whole or in part, in Voting Securities. A person shall be deemed to be the &#8220;Beneficial Owner&#8221; of, or to &#8220;Beneficially Own,&#8221; any securities that such person has Beneficial Ownership of.</font></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:5.85pt;text-align:justify;text-indent:70.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.52pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any day that is not (i) a Saturday, (ii) a Sunday or (iii) other day on which commercial banks in the State of New York are authorized or required to be closed by applicable law.</font></div><div style="height:86.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.75pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Director Criteria</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means that a person (i) qualifies as &#8220;independent&#8221; pursuant to SEC rules and regulations, applicable stock exchange listing standards and applicable corporate governance guidelines and policies, (ii) qualifies to serve as a director under the DGCL, (iii) is not an Affiliate, Associate, employee or principal of the Engaged Group or any of its Affiliates or Associates, and (iv) has the relevant experience to be a director of the Company.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.03pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Securities Exchange Act of 1934, as amended (together with the rules and regulations promulgated thereunder).</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Extraordinary Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any tender offer, exchange offer, merger, consolidation, acquisition, business combination, sale, recapitalization, restructuring, or other transaction with a person that, in each case, results in a change in control of the Company or the sale of substantially all of its assets.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Company and the Engaged Group, individually, and &#8220;Parties&#8221; means the Company and the Engaged Group, collectively.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning ascribed to such terms under the Exchange Act and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a person&#8217;s Affiliates and Associates and its and their respective directors, officers, employees, partners, members, managers, consultants, legal or other advisors, agents and other representatives acting in a capacity on behalf of, in concert with or at the direction of, such person or its Affiliates and Associates.</font></div><div style="margin-bottom:9pt;padding-left:114pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the U.S. Securities and Exchange Commission.</font></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.74pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Synthetic Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any option, warrant, convertible security, stock appreciation right or other security, contract right or derivative position or similar right (including any &#8220;swap&#8221; transaction with respect to any security, other than a broad based market basket or index) (each of the foregoing, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Derivative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), whether or not presently exercisable, that has an exercise or conversion privilege or a settlement payment or mechanism at a price related to the value of Voting Securities or a value determined in whole or in part with reference to, or derived in whole or in part from, the value of Voting Securities and that increases in value as the market price or value of Voting Securities increases or that provides an opportunity, directly or indirectly, to profit or share in any profit derived from any increase in the value of Voting Securities, in each case regardless of whether (i) it conveys any voting rights in such Voting Securities to any person, (ii) it is required to be or capable of being settled, in whole or in part, in Voting Securities or (iii) any person (including the holder of such Synthetic Position) may have entered into other transactions that hedge its economic effect.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Voting Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Common Stock and any other securities of the Company entitled to vote in the election of directors.</font></div><div style="margin-bottom:9pt;padding-left:78pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Mandatory Injunctive Relief&#59; Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.</font></div><div style="height:86.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.75pt">Each Party acknowledges and agrees that any breach of any provision of this Agreement shall cause the other Party irreparable harm which would not be adequately compensable by money damages. Accordingly, in the event of a breach or threatened breach by a Party of any provision of this Agreement, the other Party shall be entitled to seek an injunction or other equitable relief, without having to prove irreparable harm or actual damages or post a bond or other security. The foregoing right shall be in addition to such other rights or remedies that may be available to the non-breaching Party for such breach or threatened breach, including the recovery of money damages.</font></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:5.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.07pt">If a Party institutes any legal suit, action or proceeding against the other Party to enforce this Agreement (or obtain any other remedy regarding any breach of this Agreement) or arising out of or relating to this Agreement, including contract, equity, tort, fraud and statutory claims, the prevailing Party in the suit, action or proceeding is entitled to receive, and the non-prevailing Party shall pay, in addition to all other remedies to which the prevailing Party may be entitled, the costs and expenses incurred by the prevailing Party in conducting the suit, action or proceeding, including actual attorneys&#8217; fees and expenses, even if not recoverable by law.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated. Each Party agrees to use its commercially reasonable best efforts to agree upon and substitute a valid and enforceable term, provision, covenant or restriction for any of such that is held invalid, void or unenforceable by a court of competent jurisdiction.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any notices, consents, determinations, waivers or other communications required or permitted to be given under the terms of this Agreement must be in writing and shall be deemed to have been delivered (a) upon receipt, when delivered personally, (b) upon confirmation of receipt, when sent by e-mail (provided that such confirmation is not automatically generated) or (c) one Business Day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the Party to receive the same. The addresses for such communications shall be&#58;</font></div><div style="margin-bottom:12pt;padding-left:78pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If to the Company&#58;</font></div><div style="padding-left:114pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Evolent Health, Inc.</font></div><div style="padding-left:114pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">800 N. Glebe Road, Suite 500</font></div><div style="padding-left:114pt;padding-right:219.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Arlington, VA 22203 Attention&#58; Jonathan Weinberg</font></div><div style="margin-bottom:12pt;padding-left:78pt;padding-right:166.25pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;jweinberg&#64;evolenthealth.com </font></div><div style="margin-bottom:12pt;padding-left:78pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">With copies (which shall not constitute notice) to&#58;</font></div><div style="padding-left:114pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cravath, Swaine and Moore LLP</font></div><div style="padding-left:114pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Two Manhattan West</font></div><div style="height:86.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="padding-left:114pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">375 Ninth Avenue</font></div><div style="padding-left:114pt;padding-right:219.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">New York, NY 10001 Attention&#58; Aaron Gruber&#59; </font></div><div style="padding-left:114pt;padding-right:219.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Andrew Wark</font></div><div style="margin-bottom:12pt;padding-left:166.5pt;padding-right:182.5pt;text-indent:-51pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Email&#58; &#160;&#160;&#160;&#160;agruber&#64;cravath.com&#59; awark&#64;cravath.com </font></div><div style="margin-bottom:12pt;padding-left:78pt;padding-right:216.3pt;text-indent:-1.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If to the Engaged Group&#58;</font></div><div style="padding-left:78pt;padding-right:216.3pt;text-indent:34.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Engaged Capital, LLC</font></div><div style="padding-left:114pt;padding-right:189pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">610 Newport Center Drive, Suite 950 Newport Beach, California 92660 Attention&#58; Glenn W. Welling</font></div><div style="margin-bottom:12pt;padding-left:114pt;padding-right:169pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;glenn&#64;engagedcapital.com</font></div><div style="margin-bottom:12pt;padding-left:78pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">With copies (which shall not constitute notice) to&#58;</font></div><div style="padding-left:112.5pt;padding-right:169pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Olshan Frome Wolosky LLP </font></div><div style="padding-left:112.5pt;padding-right:169pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1325 Avenue of the Americas </font></div><div style="padding-left:112.5pt;padding-right:169pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">New York, NY 10019 </font></div><div style="padding-left:112.5pt;padding-right:169pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58; &#160;&#160;&#160;&#160;Ryan Nebel</font></div><div style="padding-left:112.5pt;padding-right:169pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Ian Engoron</font></div><div style="padding-left:112.5pt;padding-right:169pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;rnebel&#64;olshanlaw.com </font></div><div style="padding-left:112.5pt;padding-right:169pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;iengoron&#64;olshanlaw.com</font></div><div style="padding-left:112.5pt;padding-right:169pt"><font><br></font></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.05pt;text-decoration:underline">Governing Law&#59; Jurisdiction&#59; Jury Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement and all actions, proceedings or counterclaims (whether based on contract, tort or otherwise) arising out of or relating to this Agreement or any action of the Company or the Engaged Group in the negotiation, administration, performance or enforcement hereof shall be governed by and construed and enforced in accordance with the laws of the State of Delaware without giving effect to any choice or conflict of laws provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. Each Party irrevocably agrees that any legal action or proceeding with respect to this Agreement and any rights and obligations arising hereunder, or for recognition and enforcement of any judgment in respect of this Agreement and any rights and obligations arising hereunder brought by the other Party or its successors or assigns, shall be brought and determined exclusively in the Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware (or, if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any federal court within the State of Delaware) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Chosen Courts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). Each Party hereby irrevocably submits with regard to any such action or proceeding for itself and in respect of its property, generally and unconditionally, to the personal jurisdiction of the Chosen Courts and agrees that it shall not bring any action relating to this Agreement in any court other than the Chosen Courts. Each Party hereby irrevocably waives, and agrees not to assert in any action or proceeding with respect to this Agreement, (a) any claim that it is not </font></div><div style="height:86.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">personally subject to the jurisdiction of the Chosen Courts for any reason, (b) any claim that it or its property is exempt or immune from jurisdiction of any Chosen Court or from any legal process commenced in the Chosen Courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c) to the fullest extent permitted by applicable legal requirements, any claim that (i) the suit, action or proceeding in any Chosen Court is brought in an inconvenient forum, (ii) the venue of such suit, action or proceeding is improper or (iii) this Agreement, or the subject matter hereof, may not be enforced in or by the Chosen Courts. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Counterparts&#59; Electronic Transmission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement may be executed in two or more counterparts, which together shall constitute a single agreement. Any signature to this Agreement transmitted by facsimile transmission, by electronic mail in &#8220;portable document format&#8221; (&#8220;.pdf&#8221;) form or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document, shall have the same effect as physical delivery of the paper document bearing the original signature.</font></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.05pt;text-decoration:underline">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any waiver by any Party of a breach of any provision of this Agreement shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Agreement. The failure of a Party to insist upon strict adherence to any term of this Agreement on one or more occasions shall not be considered a waiver of, or deprive that Party of the right thereafter to insist upon strict adherence to, that term or any other term of this Agreement.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Entire Agreement&#59; Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement contains the entire understanding of the Parties with respect to the subject matter hereof. This Agreement may only be amended pursuant to a written agreement executed by each Party.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:9.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement may not be transferred or assigned by any Party without the prior written consent of the other Party. Any purported assignment without such consent is null and void </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">ab initio. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Subject to the foregoing, this Agreement shall be binding upon, inure to the benefit of, and be enforceable by and against the permitted successors and assigns of each Party.</font></div><div style="margin-bottom:9pt;padding-left:6pt;padding-right:25.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">No Third-Party Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement is solely for the benefit of the Parties and is not enforceable by any other person.</font></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.05pt;text-decoration:underline">Interpretation and Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Party acknowledges that it has been represented by independent counsel of its choice throughout all negotiations that have preceded the execution of this Agreement, and that it has executed the same with the advice of said independent counsel. Each Party and its counsel cooperated and participated in the drafting and preparation of this Agreement and the documents referred to herein, and any and all drafts relating thereto exchanged among the parties shall be deemed the work product of all of the Parties and may not be construed against any Party by reason of its drafting or preparation. Accordingly, any rule of law or any legal decision that would require interpretation of any </font></div><div style="height:86.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:5.95pt;padding-right:9.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ambiguities in this Agreement against any Party that drafted or prepared it is of no application and is hereby expressly waived by each Party, and any controversy over any interpretation of this Agreement shall be decided without regards to events of drafting or preparation. The section headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. In this Agreement, (a) the word &#8220;including&#8221; (in its various forms) means &#8220;including, without limitation,&#8221; (b) the words &#8220;hereunder,&#8221; &#8220;hereof,&#8221; &#8220;hereto&#8221; and words of similar import are references to this Agreement as a whole and not to any particular provision of this Agreement and (c) the word &#8220;or&#8221; is not exclusive.</font></div><div style="margin-bottom:9pt;padding-left:33.4pt;padding-right:33.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK&#93;</font></div><div style="height:86.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><div id="idc3d654e76d0462c95f5f0d4a7fc1817_4"></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, each Party has executed this Agreement or caused the same to be executed by its duly authorized representative as of the date first above written.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"> </font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.533%"><tr><td style="width:1.0%"></td><td style="width:12.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.404%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.30pt">EVOLENT HEALTH, INC.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-right:-12.84pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.5pt;padding-right:-25.68pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:0.5pt;padding-right:-25.68pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Jonathan D. Weinberg</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.5pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.30pt">Name&#58; Jonathan D. Weinberg</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; General Counsel and Secretary</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:30.82pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:12.80pt">Title&#58; General Counsel and Secretary</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:6.22pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ENGAGED CAPITAL FLAGSHIP MASTER FUND, LP</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6.65pt;padding-left:4.04pt;padding-right:4.04pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.05pt">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6.65pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.05pt">Engaged Capital, LLC</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.55pt">General Partner</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt;padding-right:-2.63pt"><font><br></font></div><div style="padding-left:4.04pt;padding-right:4.04pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.30pt">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt;padding-right:-2.63pt"><font><br></font></div><div style="padding-right:-5.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.30pt;text-decoration:underline">&#160;&#47;s&#47; Glenn W. Welling</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.05pt">Name&#58; Glenn W. Welling</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.55pt">Title&#58; Founder and Chief Investment Officer</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.30pt">ENGAGED CAPITAL CO-INVEST XI-B, LP</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6.65pt;padding-left:4.04pt;padding-right:4.04pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.05pt">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6.65pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.05pt">Engaged Capital, LLC</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.55pt">General Partner</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt;padding-right:-2.63pt"><font><br></font></div><div style="padding-left:4.04pt;padding-right:4.04pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.30pt">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt;padding-right:-2.63pt"><font><br></font></div><div style="padding-right:-15.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.30pt;text-decoration:underline">&#47;s&#47; Glenn W. Welling</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.05pt">Name&#58; Glenn W. Welling</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.55pt">Title&#58; Founder and Chief Investment Officer</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.30pt">ENGAGED CAPITAL, LLC</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt;padding-right:-2.63pt"><font><br></font></div><div style="padding-left:7.37pt;padding-right:-25.68pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.30pt">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt;padding-right:-2.63pt"><font><br></font></div><div style="padding-right:-15.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.30pt;text-decoration:underline">&#47;s&#47; Glenn W. Welling</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:35.47pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.05pt">Name&#58; Glenn W. Welling</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.05pt">Name&#58; Glenn W. Welling</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:35.47pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.55pt">Title&#58; Founder and Chief Investment</font></div><div style="padding-left:35.47pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:12.80pt">Officer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.55pt">Title&#58; Founder and Chief Investment Officer</font></div></td></tr></table></div><div style="margin-top:0.5pt"><font><br></font></div><div style="height:99.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Signature Page to Cooperation Agreement&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.533%"><tr><td style="width:1.0%"></td><td style="width:12.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.30pt">ENGAGED CAPITAL HOLDINGS, LLC</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt;padding-right:-2.63pt"><font><br></font></div><div style="padding-left:7.37pt;padding-right:-25.68pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.30pt">By&#58;  </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt;padding-right:-2.63pt"><font><br></font></div><div style="padding-right:-15.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.30pt;text-decoration:underline">&#47;s&#47; Glenn W. Welling</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.05pt">Name&#58; Glenn W. Welling</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:12.55pt">Title&#58; Sole Member</font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt;padding-right:-2.63pt"><font><br></font></div><div style="padding-right:-15.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.30pt;text-decoration:underline">&#47;s&#47; Glenn W. Welling</font></div></td></tr></table></div><div><font><br></font></div><div style="padding-left:228.7pt"><font><br></font></div><div style="height:99.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Signature Page to Cooperation Agreement&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><div id="idc3d654e76d0462c95f5f0d4a7fc1817_7"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4.5pt;padding-left:34.87pt;padding-right:34.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EXHIBIT A</font></div><div><font><br></font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Engaged Capital, LLC</font></div><div style="padding-left:5.95pt;padding-right:269.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Engaged Capital Flagship Master Fund, LP Engaged Capital Co-Invest XI-B, LP</font></div><div style="padding-left:5.95pt;padding-right:321.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Engaged Capital Holdings, LLC Glenn W. Welling</font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><div id="idc3d654e76d0462c95f5f0d4a7fc1817_10"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3pt;padding-left:34.92pt;padding-right:34.92pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit B</font></div><div style="margin-bottom:12pt;padding-left:34.9pt;padding-right:34.9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Form of Press Release</font></div><div style="padding-left:34.87pt;padding-right:34.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;See attached&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:135pt"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:135pt"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:134px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Evolent Health Announces Changes to Board of Directors</font></div><div style="padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font><br></font></div><div style="padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Richard &#8220;Rick&#8221; Jelinek to Be Named Chair of the Board at 2025 Annual Meeting</font></div><div style="padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font><br></font></div><div style="padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Company Continues Board Refreshment Efforts with Brendan Springstubb&#8217;s <br>Appointment as New Independent Director </font></div><div><font><br></font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, FEBRUARY 4, 2025 &#8211; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Evolent Health, Inc. (NYSE&#58; EVH) (&#8220;Evolent&#8221;), a company focused on achieving better health outcomes for people with complex conditions, today announced changes to its Board of Directors as part of the Company&#8217;s ongoing commitment to strong corporate governance and to collaboration with shareholders. </font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Rick Jelinek, who joined the Evolent Board as an independent director in 2023, will be named Chair of the Board at the 2025 Annual Meeting, succeeding Cheryl Scott. Mr. Jelinek is currently Managing Partner of Czech One Capital Partners and previously served as Executive Vice President of CVS Health.</font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, Brendan Springstubb has joined the Evolent Board as an independent director. Mr. Springstubb brings more than 20 years of experience investing in premier healthcare companies and has extensive experience working with public companies on strategy, investor communications and value creation.  </font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Further, the Board intends to refresh an independent director seat in advance of the 2025 Annual Meeting pursuant to a previously initiated search process being overseen by the Board&#8217;s Nominating and Governance Committee. With the additions announced today, Evolent will have added five new independent directors to the Board in the past three years.</font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ms. Scott said, &#8220;The rotation of the Chair role and our continued Board refreshment builds on actions previously taken by the Evolent Board to ensure that our corporate governance is aligned with best-in-class practices. It has been an honor to serve as Chair of the Board since 2022.&#8221;</font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font><br></font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ms. Scott continued, &#8220;As we pursue investments and initiatives that drive both better health outcomes and a strong future for the Company, we are pleased to deepen the capital markets and finance experience on Evolent&#8217;s Board with Brendan&#8217;s appointment.&#8221; </font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font><br></font></div><div style="padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Glenn W. Welling, Founder and CIO of Engaged Capital, one of Evolent&#8217;s largest shareholders commented, &#8220;Having worked with Brendan for over 15 years, I know he will be a strong shareholder advocate in the Evolent boardroom. As evidenced by its consistent new business wins </font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and high customer retention, Evolent is a critical service provider to its clients, and I am confident Brendan will be a great partner to Seth and the team as Evolent leverages its strong competitive position to create value for shareholders.&#8221;  </font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Seth Blackley, co-founder and Chief Executive Officer of Evolent stated, &#8220;Evolent has long benefitted from a Board that brings skills, experience and a shared commitment to advance our mission. Rick and Brendan will be critical to ensuring we are creating value for all our stakeholders going forward and I also want to thank Cheryl for leading the Board the last 3 years.&#8221; </font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font><br></font></div><div style="padding-left:5.75pt;padding-right:10.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Brendan Springstubb</font></div><div style="padding-left:5.75pt;padding-right:10.1pt"><font><br></font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mr. Springstubb joins our Board with two decades of experience leading investments in publicly traded healthcare companies. He is currently Principal of Bedell Canyon LLC, where he provides analysis, engagement strategy, and fundraising assistance to public equity investment firms, with an emphasis on companies in the healthcare sector. </font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font><br></font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Prior to Bedell, Mr. Springstubb was a Principal at Engaged Capital, LLC, one of Evolent&#8217;s largest shareholders for the past four years, where he was responsible for sourcing and managing investments primarily in the healthcare industry. Previously, he held multiple roles at Relational Investors, LLC, where he covered the healthcare sector.  </font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font><br></font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mr. Springstubb was previously a member of the SunOpta Inc. Board of Directors, serving as the Chair of the Compensation Committee. </font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font><br></font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mr. Springstubb holds a master&#8217;s degree from Johns Hopkins University in biotechnology and a bachelor&#8217;s degree in molecular biology and economics from Pomona College. He is a CFA Charterholder and a Certified Financial Risk Manager. </font></div><div style="padding-left:6pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Evolent Health</font></div><div style="padding-left:6pt"><font><br></font></div><div style="padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Evolent (NYSE&#58; EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting https&#58;&#47;&#47;ir.evolent.com.</font></div><div><font><br></font></div><div style="padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward-Looking Statements &#8211; Cautionary Language</font></div><div><font><br></font></div><div style="padding-left:6pt;padding-right:9.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Certain statements made in this release and in other written or oral statements made by us or on our behalf are &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995 (the &#8220;PSLRA&#8221;). A forward-looking statement is a statement that is not a historical fact and, without limitation, includes any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words like&#58; &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;aim,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;shall,&#8221; &#8220;may,&#8221; &#8220;might&#8221; and other words or phrases with similar meaning in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, future appointments to our board of directors, trends in our businesses, prospective services, future performance or financial results, and the closing of pending transactions and the outcome of contingencies, such as legal proceedings. </font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:6pt;padding-right:9.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We claim the protection afforded by the safe harbor for forward-looking statements provided by the PSLRA. These statements are only predictions based on our current expectations and projections about future events. Forward-looking statements involve risks and uncertainties that may cause actual results, level of activity, performance or achievements to differ materially from the results contained in the forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Our Annual Report on Form 10-K for the year ended December 31, 2023, as amended, subsequent Quarterly Reports on Form 10-Q and other documents filed with the U.S. Securities and Exchange Commission include risk factors that could affect our businesses and financial performance. Moreover, we operate in a rapidly changing and competitive environment. New risk factors emerge from time to time, and it is not possible for management to predict all such risk factors.</font></div><div style="padding-left:6pt;padding-right:9.7pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;padding-right:9.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Further, it is not possible to assess the effect of all risk factors on our businesses or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances that occur after the date of this release.</font></div><div><font><br></font></div><div style="padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Evolent Contact</font></div><div><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Seth R. Frank</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Vice President, Investor Relations</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sfrank&#64;evolent.com</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">571-895-3919</font></div><div><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:80%">&#91;&#91;6677635&#93;&#93;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>a202524exhibit991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i900dfa95a8f0400aa2f3a3ec88ac81a1_1"></div><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 99.1</font></div></div><div style="padding-left:135pt"><img alt="image_01a.jpg" src="image_01a.jpg" style="height:134px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Evolent Health Announces Changes to Board of Directors</font></div><div style="padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font><br></font></div><div style="padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Richard &#8220;Rick&#8221; Jelinek to Be Named Chair of the Board at 2025 Annual Meeting</font></div><div style="padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font><br></font></div><div style="padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Company Continues Board Refreshment Efforts with Brendan Springstubb&#8217;s <br>Appointment as New Independent Director </font></div><div><font><br></font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, FEBRUARY 4, 2025 &#8211; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Evolent Health, Inc. (NYSE&#58; EVH) (&#8220;Evolent&#8221;), a company focused on achieving better health outcomes for people with complex conditions, today announced changes to its Board of Directors as part of the Company&#8217;s ongoing commitment to strong corporate governance and to collaboration with shareholders. </font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Rick Jelinek, who joined the Evolent Board as an independent director in 2023, will be named Chair of the Board at the 2025 Annual Meeting, succeeding Cheryl Scott. Mr. Jelinek is currently Managing Partner of Czech One Capital Partners and previously served as Executive Vice President of CVS Health.</font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, Brendan Springstubb has joined the Evolent Board as an independent director. Mr. Springstubb brings more than 20 years of experience investing in premier healthcare companies and has extensive experience working with public companies on strategy, investor communications and value creation.  </font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Further, the Board intends to refresh an independent director seat in advance of the 2025 Annual Meeting pursuant to a previously initiated search process being overseen by the Board&#8217;s Nominating and Governance Committee. With the additions announced today, Evolent will have added five new independent directors to the Board in the past three years.</font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ms. Scott said, &#8220;The rotation of the Chair role and our continued Board refreshment builds on actions previously taken by the Evolent Board to ensure that our corporate governance is aligned with best-in-class practices. It has been an honor to serve as Chair of the Board since 2022.&#8221;</font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font><br></font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ms. Scott continued, &#8220;As we pursue investments and initiatives that drive both better health outcomes and a strong future for the Company, we are pleased to deepen the capital markets and finance experience on Evolent&#8217;s Board with Brendan&#8217;s appointment.&#8221; </font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font><br></font></div><div style="padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Glenn W. Welling, Founder and CIO of Engaged Capital, one of Evolent&#8217;s largest shareholders commented, &#8220;Having worked with Brendan for over 15 years, I know he will be a strong shareholder advocate in the Evolent boardroom. As evidenced by its consistent new business wins </font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and high customer retention, Evolent is a critical service provider to its clients, and I am confident Brendan will be a great partner to Seth and the team as Evolent leverages its strong competitive position to create value for shareholders.&#8221;  </font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Seth Blackley, co-founder and Chief Executive Officer of Evolent stated, &#8220;Evolent has long benefitted from a Board that brings skills, experience and a shared commitment to advance our mission. Rick and Brendan will be critical to ensuring we are creating value for all our stakeholders going forward and I also want to thank Cheryl for leading the Board the last 3 years.&#8221; </font></div><div style="padding-left:6pt;padding-right:9.8pt;text-align:justify"><font><br></font></div><div style="padding-left:5.75pt;padding-right:10.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Brendan Springstubb</font></div><div style="padding-left:5.75pt;padding-right:10.1pt"><font><br></font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mr. Springstubb joins our Board with two decades of experience leading investments in publicly traded healthcare companies. He is currently Principal of Bedell Canyon LLC, where he provides analysis, engagement strategy, and fundraising assistance to public equity investment firms, with an emphasis on companies in the healthcare sector. </font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font><br></font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Prior to Bedell, Mr. Springstubb was a Principal at Engaged Capital, LLC, one of Evolent&#8217;s largest shareholders for the past four years, where he was responsible for sourcing and managing investments primarily in the healthcare industry. Previously, he held multiple roles at Relational Investors, LLC, where he covered the healthcare sector.  </font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font><br></font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mr. Springstubb was previously a member of the SunOpta Inc. Board of Directors, serving as the Chair of the Compensation Committee. </font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font><br></font></div><div style="padding-left:5.75pt;padding-right:10.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mr. Springstubb holds a master&#8217;s degree from Johns Hopkins University in biotechnology and a bachelor&#8217;s degree in molecular biology and economics from Pomona College. He is a CFA Charterholder and a Certified Financial Risk Manager. </font></div><div style="padding-left:6pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Evolent Health</font></div><div style="padding-left:6pt"><font><br></font></div><div style="padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Evolent (NYSE&#58; EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting https&#58;&#47;&#47;ir.evolent.com.</font></div><div><font><br></font></div><div style="padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward-Looking Statements &#8211; Cautionary Language</font></div><div><font><br></font></div><div style="padding-left:6pt;padding-right:9.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Certain statements made in this release and in other written or oral statements made by us or on our behalf are &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995 (the &#8220;PSLRA&#8221;). A forward-looking statement is a statement that is not a historical fact and, without limitation, includes any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words like&#58; &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;aim,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;shall,&#8221; &#8220;may,&#8221; &#8220;might&#8221; and other words or phrases with similar meaning in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, future appointments to our board of directors, trends in our businesses, prospective services, future performance or financial results, and the closing of pending transactions and the outcome of contingencies, such as legal proceedings. </font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:6pt;padding-right:9.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We claim the protection afforded by the safe harbor for forward-looking statements provided by the PSLRA. These statements are only predictions based on our current expectations and projections about future events. Forward-looking statements involve risks and uncertainties that may cause actual results, level of activity, performance or achievements to differ materially from the results contained in the forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Our Annual Report on Form 10-K for the year ended December 31, 2023, as amended, subsequent Quarterly Reports on Form 10-Q and other documents filed with the U.S. Securities and Exchange Commission include risk factors that could affect our businesses and financial performance. Moreover, we operate in a rapidly changing and competitive environment. New risk factors emerge from time to time, and it is not possible for management to predict all such risk factors.</font></div><div style="padding-left:6pt;padding-right:9.7pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;padding-right:9.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Further, it is not possible to assess the effect of all risk factors on our businesses or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances that occur after the date of this release.</font></div><div><font><br></font></div><div style="padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Evolent Contact</font></div><div><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Seth R. Frank</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Vice President, Investor Relations</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sfrank&#64;evolent.com</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">571-895-3919</font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.720%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>evh-20250203.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:dafe9667-b439-427c-95c8-7ae590833bc7,g:ffe81467-a892-473b-b900-eb8e6518a3c9-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:evh="http://www.evolenthealth.com/20250203" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.evolenthealth.com/20250203">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="evh-20250203_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="evh-20250203_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.evolenthealth.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>evh-20250203_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:dafe9667-b439-427c-95c8-7ae590833bc7,g:ffe81467-a892-473b-b900-eb8e6518a3c9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_57226ab8-a335-4112-87cf-87952c309168_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_f2d364a5-0392-410e-9a53-f4f3bd1038a2_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_d505fd5a-6273-47fa-a622-a0c827e0863b_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_12fa675d-cdaf-4e06-bfb5-89450d8e8974_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2e87371d-59e1-4e7a-9f84-77eedb5055a9_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_6402d3f0-e8fe-471b-ac86-80d09235fc3a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_a0d0aefd-0719-4c97-b951-2e534d1552d5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_ff4b37be-529a-40b1-a423-30b44284938c_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a6cad3f6-2552-41a1-9bd5-aa48b75d0a52_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_e960a9aa-0cf0-4b1b-b78d-cbb448c26590_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_6da0d525-c60f-4eb0-acba-b9569a332c22_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_a9e9d255-b693-4337-96f1-55b46e0fd4d0_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_b54988c9-8031-4a72-942c-7a7eabe293b0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7bfc41b8-3bbf-497d-b910-621e4b4e34a7_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_81073078-3499-49ac-b81e-b26dbcc8e075_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_1db8acef-e979-461b-ac03-313ce3e97fe6_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_67b1ec88-ec0a-4454-9d7c-1d4aca69ed45_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_bcf36b24-1aa1-4db3-9c3f-17af8c0e2325_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_6b4dc46d-0ace-4f1f-8d9b-2a4bb913f217_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_99db8f18-0efe-4db0-839d-87f21231bb8e_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_a0d1f26e-62e7-41eb-ad6c-af71a7ab1b12_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c091ddf1-926b-4f37-b824-bbcb93aa55ec_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_49857384-c86a-4960-93a6-0b454adc8a6b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_5eab59ca-753b-4a13-9f3d-139ca28e3e5e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>evh-20250203_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:dafe9667-b439-427c-95c8-7ae590833bc7,g:ffe81467-a892-473b-b900-eb8e6518a3c9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.evolenthealth.com/role/Cover" xlink:type="simple" xlink:href="evh-20250203.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.evolenthealth.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_54331f50-5ef9-45bc-a78b-3e891a560fd8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_DocumentType_54331f50-5ef9-45bc-a78b-3e891a560fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9a6b70f0-1b1c-4469-bba8-3c1e2412928b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_DocumentPeriodEndDate_9a6b70f0-1b1c-4469-bba8-3c1e2412928b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_595757e8-1ebe-47e1-ba2a-3ecb9a794de3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_CurrentFiscalYearEndDate_595757e8-1ebe-47e1-ba2a-3ecb9a794de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b0ca5b9a-07d9-490e-8d1d-247a56978a64" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_EntityRegistrantName_b0ca5b9a-07d9-490e-8d1d-247a56978a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c88d96a2-047a-428c-a1af-154fd9cf31f5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c88d96a2-047a-428c-a1af-154fd9cf31f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2c0e7f10-6085-4ffb-b771-7e9c91be3642" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_EntityFileNumber_2c0e7f10-6085-4ffb-b771-7e9c91be3642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_052c0e71-9700-457b-afc4-9e2aef95b503" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_EntityTaxIdentificationNumber_052c0e71-9700-457b-afc4-9e2aef95b503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5daeff4c-0072-4582-8bd5-aaecc36cd789" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_EntityAddressAddressLine1_5daeff4c-0072-4582-8bd5-aaecc36cd789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_553bfab1-ce29-4f05-a20a-e79de72aee9b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_EntityAddressAddressLine2_553bfab1-ce29-4f05-a20a-e79de72aee9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2efe2b81-2d7e-4250-90ba-a52c65cf6c48" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_EntityAddressCityOrTown_2efe2b81-2d7e-4250-90ba-a52c65cf6c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_8e15ae78-493d-4ef8-9b4b-3d044db04315" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_EntityAddressStateOrProvince_8e15ae78-493d-4ef8-9b4b-3d044db04315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4e3715f7-9bc8-46fc-84cb-693b1ced6409" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_CityAreaCode_4e3715f7-9bc8-46fc-84cb-693b1ced6409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_89334a44-a1ed-4eb1-8b80-c5617b8f206f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_LocalPhoneNumber_89334a44-a1ed-4eb1-8b80-c5617b8f206f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_36df99ec-775d-422d-888b-056fc7bf69bd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_EntityAddressPostalZipCode_36df99ec-775d-422d-888b-056fc7bf69bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_8ff78231-03af-4dcf-a817-84a4ecb93de3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_WrittenCommunications_8ff78231-03af-4dcf-a817-84a4ecb93de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_5d41da5c-546f-4fb5-b032-a5512b79c643" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_SolicitingMaterial_5d41da5c-546f-4fb5-b032-a5512b79c643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_a9140a94-8e31-4e50-ba8c-4e18ffe1a172" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_PreCommencementTenderOffer_a9140a94-8e31-4e50-ba8c-4e18ffe1a172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_88b9d90e-1e5c-4ac5-87c7-337fa8088293" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_88b9d90e-1e5c-4ac5-87c7-337fa8088293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_14f9edd9-5d1c-448b-abf9-740672c5c01a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_Security12bTitle_14f9edd9-5d1c-448b-abf9-740672c5c01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cd16de7c-2dee-46cb-a080-790bf1e303d1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_TradingSymbol_cd16de7c-2dee-46cb-a080-790bf1e303d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_67d4325c-26cc-4de1-9861-9e9bc5e17d40" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_SecurityExchangeName_67d4325c-26cc-4de1-9861-9e9bc5e17d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_2ea5c852-98fc-43ee-b78f-4a141f43a468" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_EntityEmergingGrowthCompany_2ea5c852-98fc-43ee-b78f-4a141f43a468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e7ca7b71-1275-4c0a-941a-9e5743461301" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_AmendmentFlag_e7ca7b71-1275-4c0a-941a-9e5743461301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_483497a5-7b9e-4fde-bfaa-2e0055c3631c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fc3b1f11-2fe9-4921-91fe-f398feba58f4" xlink:to="loc_dei_EntityCentralIndexKey_483497a5-7b9e-4fde-bfaa-2e0055c3631c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_01a.jpg
<TEXT>
begin 644 image_01a.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" *V!=P# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBBI;L 444@)'WJ:=T M% Z4$@=:8KA13/F_O4Y3D=:6H]Q:*
M**8!113=S9P12<DMP'444470KA1113&%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?O@U/-9ZBNF.HHHJAA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M485XSCN>'F*BG='HAST/:J.O:G%H^F3ZG=$B&"(N^WK5Y<,?FKD/CQK0\/\
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M&@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M 2!R:,C&:0XQS1PPVK2N ;AZTI('6F9"\ ?C1N/>GK:X6=AP8'H:4D#K30<#
MY5HWGHRTE<-10RGO2Y!Z&F[A_<%*",9%#N@(+IBT;;6VXYS7XS?\'$GQM\02
M^-]'^&VB^)RVGFU9[NS@E(Q()"!G!]#7[)ZM"\MA/%$Q5GB8!AVXK^>K_@M=
M\./&G@W]J?4+_P 17+S6U_))-9-(_1-P' ^M?4\)T:5;&7F>_P /4E4Q#<CX
MQGD8L [$J.JJ<5'($(X1@/0/0"",BEX[U^U1Y(TU&*T/TJ$>6*2"&>6)EDMY
M,-U.1G/^%?JE_P $"/VSD\,^(Y?@?XXU^><WSC^S(Y9681C 4*,Y[U^5T0\L
MA8>C@@$]J^MO^"._AO6]0_;%\/2:?92RI;2(;B1$)"X=>XKY[B?#4*^#E*>C
ML>3G5"E5PSE/1G]&MNXD3<#4I.>W-5[--EN%SC-60<+FOPV?+&;9^6R:]HTA
MC @[L9P.E?G?_P %U/V7+[XC?"=/B'X7\/"2?3W\R]GC RJ $FOT1Y)K ^)/
MP_T'XF>#[_P9XDMUDM+^W:*8,,\&N[*<;+!8Z-=;(THU>2H?RMW$4D+&SEY9
M)2O3IBDV!I,HV=PXS[5^@'_!0#_@C;\5/A+XAO\ QK\&M).IZ5<2O+]EC(RN
M26X"@GN*^$/$?@[Q/H&HS:'J_AZ^M;B%L/ UJXVGOR17[KE^;X7,Z2E&6I]'
M2KTZE/5F:IWEPHSL^]2J DB2 ;_,.T)FK":9K#82WTZY4'@I]G;YC^5>Z?LO
M_P#!/;X^?M,:S;:=HO@V6RTVX8*;^0,H&>_S#%=F+QN&PF'YG-:%2J4H1]UG
M=?\ !(_]FSQK\9/VC](\1:1IGF:?H-V)[TLF553N7OUYK^@/1;06.FP6BH%$
M<2KA1@# Q7S_ /\ !/\ _88\*?L<?#.+0;14FU2X7_3;L*,GH<9''!S7T6H!
MP%_6OQ#B3-O[3Q>FR/G\55]I(7!V@@5S/QATZ#6OAUJVES#=YEFPQCZ5U&!C
M9FJNHVL5S:O#<1[D(PRXZBO!H3=.O%]F<<[\NA_-+\?-+?3/BQKUH 4/]K7
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 $9&*:""-I'2G$X&:
M80?O>M3=<U@(IY&&5C'..,U\)_\ !<?]I?Q7\"_V>1I/A>1EFUMI+:5XVP5
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M4%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@!),[>*: 67'I3FQCFD!1>AHLKW)]ZXUQM&< GM5+5M%M-:M)+*
M^@62*5=KQN.&'H:OG:W -)MQU:DIU(3O$N,IPE='QA\=O^"-/[-'Q8UN7Q##
MX>CM+JXD+RF*)0"<YKL/V8?^"7G[.G[..H1^(M \*V\VIQ+\L\T*Y4^H(^E?
M3[[6((7)]:9R[$%=IKTZF>9E5PZHN;LCTIYQC94?9\SL,M(E2,*%.1P<U,1M
M&/6D3:O&<FE W'<>E>;S2?Q'F.[ES2%0]J=2#'44M 7N%%%% !1110 4444
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MGX3>*?"VL>%=1DTG6K1H[B&9DDC*X(Q68RB-RC.IR/EQV^M?JW^TO_P3_P#
M7QFN9->TR 6-[R=R<!VY[**^./%7_!-?X[Z*99[;1#+"LCA2(>2H/!Z^E?T?
MDGB)E.88>,<1)1G;J?Q]Q1X6\09-C9_5X.I!N^FI\U#KPP/TIPM6ED0#'WN
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M[']*4* ,4M% ;@!@8%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M _&_Q@/^F<O_ *(6OZ+$Z?C7R>/@J==I'92=XB@@C(HHX H!R,UR&G4****
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M 4444 %%%% !1110 '@&F!B2.:>W0_2F+U'UH?PLG[16UG_CQG_ZYFOX^/\
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M5,WWQ4%HP58U)ZH/Y5,Q!.0:^-DTI'8MA]%,WMZT;V]:.:(Q]%,WMZTOF*,
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M .@&,'\J1BC*04/O7\N(_P"#KW]OPXQI>G9(SC[5-7L?[#7_  <7_P#!1/\
M:8_:/\,?#./P9'>6-]JD2:B;229S'$6P2:BIEM6C"XXUN8_HK'EGD= ...E.
MC4(NT-FLSPI>7=_X?LM0U&(I-/9QR3)C[KE03^M::$$GBO-CS<UF;[CJ**"<
M5;=@"F2$GY1^)IWF(20&R1U ICNA;&\ GI4MSMH&@%XT&T#/KBF&Y0-]Y@,X
MQBO)/VBOVV/V>_V8_#M_J7Q-^)6E6-W8P/*=.FNU69PHYVJ3S7Y)_MQ?\'9'
M@O3O#USH7[+^@S2ZK#(RI<7JE$; X.5;UKHH82K6>J,Y32/V[UGQ1X7\/1[_
M !!XALK)6Z-=W21C_P >(KC?B%^U#\ _AAH,OB7Q3\5M$6VB4EA%JD#G'T#U
M_)_^UW_P7?\ VYOVM+.*TU;QQ/H,<?7^R[M^1@#^*OF/Q'^U+^TAXPLFTOQ/
M\9-:O+9N&BFN 0?TKTX9.W9R,O;6/ZP?$/\ P< _\$Y?#.IRZ7?_ !3<O$Q#
M&*UW#]'JA_Q$3_\ !-#_ **G<_\ @O/_ ,57\B$ZM/,T\ZB9W.6DDZFH_LR'
M@P+78LGII"]LC^O,_P#!Q-_P30[_ !2N?_!>?_BJ%_X.)O\ @F>>5^*EU_X+
MS_\ %5_(8+2'/-NE MHQTMTJ?['@]@]NC^PKP9_P7T_X)S>.]=A\/Z/\5I!/
M*P"F>UV+^9?%?3_A']HGX(>.-)AU_1?B=H+03(&C9]8@5L$9Z;_>OX7;.YN]
M-G%WIQ$,J_<D0\J?6O0- _:Q_:8\.6J:?I'QMUVU@C4"..&Y  Q^%95<HLM!
MJLC^XK3M>T/7+8:AHFJ6M[&.CVUPLB_FI-6DG5FW;V _NE:_D>_9-_X.&/V[
MOV8/#J>$K3Q8^MP;LM)J5V^0 <_PU^HO[$7_  =:?!GQIX?T?PM^T1I4]GKE
MU+''-=1)F($G!)9F]Q7GU<LJT]4BE6N?M"LF0./K3B0.37FWP._:B^!_[0>F
MQZG\*OB'INK^9;B:2*TNE=H@>S =#7HVX,0H;MTKA:<79FR:DAX(/(HIJNH
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M='_$1+_P30_Z*E<_^ !_^*K^0XVT1^80+GN*3[.G_/NE;O)Z2>A/MS^O(?\
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M/^"G?[9OQR\=W7CK5?C1K&G27/(M[.[^5>OJ/>O&_&WQ;^*GQ'D\WQ[X[O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA!XKM]3LY%#,()=S(<9P3@>M?P]Q;HE^5OF'0^E?7W_!+#_@K'\:_P#@GO\
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M-Q&7TJVQO&I)']V:7*21JRJ"CJ"''0CM4B@!<$Y7M7Y>?\$ _P#@LE8_MO>
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^9W]LG_@U0^/?P0\):E\0_A/KQUY8YP+;2T>,G:<]D!;C%?EM\9/@/\ %SX
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ME&VH\<#%-E^[]_:?44ZH97&<,O7O7GRDXK0U>Q#?WMO:6S75U=I#&HW,\C
M =22:_GO_P"#H#_@J;=^)?%B_LM?!CQPTFF0 KK)LY@09?F5A\I.1TK]+?\
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M5<#T%+L'J:XI8VNY;FKIH_/&X_X-J_\ @FJJ;&^%]MAN.+=NO_?=?'W[9/\
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M1_P03_;*U#]KG]BC1M5U=%2YTF'[*RG&[;'B,=/]VOY#HU4 AVPQ.!7[0?\
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M^+Q!_P!?1_FU>KE>Z,\1\)\:I]\_44[^/\::GWS]13OX_P :^G.%;#'^X/\
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M_0T0_P#@0G^-'_$2[^PO_P!#1#_X$)_C1]3Q/8.>)^D>\>AI&92,GM7YN_\
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M1P70(R""K$_RKR8+O.T=Z^G_ /@E%X[^"OPP_:FT3XH?&'5([:UT*[CF19'
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M9@G- SL->8G=7-ALTR(#E^G45^/'_!UA^V_IWPM^!=G^S5;V[M=^(T%RQCD
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M&-D1D)P6ZBBOH'[S.6P8SP1FNZ^!/[-WQ:_:0UN3P[\)?#DE]<0 &6.W5F8
MG&2 #WKA<@<DX]Z_6K_@TNUGX=V?[5NOZ9XUN+(/>:;#'9)<CEY//S@?A6=;
M$/#TVRJ>K/B>3_@E!^VH)"(_A1?DIU_T:3G_ ,=I/^'4G[;/_1)K[_P&D_\
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MAQX&MIA<6OA2TBD4\2)  14RS:4X\MMQJE9F;\$_"R>$?AAH6@B$(;73T1E
MZ'%=;$&#')^E(BI'$(HH]BKT%/3K^%>/*5YFR0ZODW_@LW_R9!XI_P"O7_&O
MK*ODW_@LW_R9!XI_Z]?\:WPW\>(2^$_CH\;?\C?J/_7TU9E:?C;_ )&_4?\
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ME\=Y(T8UY&;U%&CR([:"NCW@*!T%+117SATC5^^:\D_;@_Y-?\7_ /8*D_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&<XKCQF'6*@TC6$K,_N?$K+\Q.1G!/I4VX!>>:_-W_@B]_P7!^%G[=?PTL_
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M?@GJ^JZAKNISZMK,\D]W<2M)//*V2[,<DY_&O<PF7>TCS3V,)U&EH?O_ /\
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MV-M=_P"PI!_Z(K]?/X/PKXW'I^V9VTMA$'&?6G4B?=%+7*MC4****8!1110
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MQD&EPR7T)CVD3%0&R/7BO=438,9)IL,*1*%10% X %/KY"I-U:AVQ5D%%%%
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MC^RM^PYX;L%M_"5CK>OQ$^=JTT"N,CI]]=WK7G5LSITKHUC1N?GS_P $7O\
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M:=B^E&Q?2K56HE9-BY4>+?\ # /[(7_1$M%_\ (O_B:/^& ?V0O^B):+_P"
M$7_Q->T[%]*-B^E/VM7^9BY4>*G_ ()__LALNW_A2NB@$_\ /A%_\37<_"WX
M'_"OX+V4VG_#7PA9Z5#<.'E2U@5-QQC/R@=J['8OI1L7TH=6K)6;8*,5T!0
MH ]*6BBLK).Y04444P"BBB@ HHHH **** "FF-&;<1GBG44 )L7THVKZ=*6B
MDTF GEIZ5F:_X9T3Q%IT^FZQI-M=0S(4ECFA5MP].16I3&0.V\.5P:I-QV%9
M'SU\4_\ @F9^R%\6_#=]H>L?"+2H3?(PFEBM8T;)[@A<U\.^+?\ @TR_8J\0
M:S+J<&JW%NDCLRQK)(0,G/K7ZS/Y3\.F?<"@1Q[?+C!7Z"MX8NO3VDR7!,_!
M/]H[_@T72&:>3X$>)"Z[3Y(E)Y/;[S5\RZK_ ,&G?[>-M>F.RFMWCSP=\?\
M\57]0I1N%= RCOFE*C'R*!GUK:.95UU)]E$_ER'_  :@?M]ODB2WS_=WQ_\
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MDQY..M.9#NW%L =JZX8ZO#:1/(NQ_-7\6O\ @TI_:IL-6D?X::S#/:ESMW%
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M(QV.A/X5I"K5ALQ<J/R.U3_@TH_8KN;RXN8?$-S&9G+*H:4A<G/K7S[^T/\
M\&BY@,[? GQ:9$_Y8&4'G_OIJ_?,J"0J$ #KBF$*_P R9'/I6T<;6@[N1G.F
MFM$?R]WW_!IS^WM!>,+.XMWCS\K;H_\ XJOT%_X(!_\ !&;]I;_@G1\8]<\;
M?%]XFL[ZP$481D^]Y@;L?05^P*I^[SC<?>FLF5PT:$$=SWK2ICZE6-FPC3L+
M;JZ1[6;))S4A4$Y(J,;RJ[\*1V4YXJ6O/BTVS4****L HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ (!.2*" >
MHHHH *,#KBBBIY4 C GIB@ C[Q&*6D?[IIV0"X Z"C SFH\GUIZMGBA*P"@
M# %%%%,74****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4UD+9!/%.HH :$8< T;7
M_O?K3J*3:6X#=K#O2E0P^84M%+W6 C!=O(XI-Z^E.(R,4T( <DT<J =U'%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ!;H\LK[ B[F9C@"I#(H7<#D>U9WBK2#KV@7>D&X9!<0E0Z]1F@#\\/VZ/\
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MP*3<,XI:!IW"BFM+&@!=L9Z9I2R@@$CD\4#%HI-RGH>E()48@ ]>E #J*0N
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M9QG\: '44UI8T4,S@ ]#0)DYSD8&>: '4QSB0>A'-.#J<8YSZ4UVVO@=QS0
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MC1K'1+#[3?7U[-&45=P4G*_6N3_:Z_X.'/V2OV:O%A\+Z'?KXG*'83I5RG#
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M '@)TZU]+?%SXA6'PI^&^L?$/5XA-!I%F9Y(TX8@$#O]:_'?_@TSW-HGC")
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MFD:QC"Y_$T"/B;X[?\$*/V)OC4LU_<>#OLEUY3+$\ 10&(X)POK7Y4_M8?\
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MEEO92REB<E@'/3)K]E_^#?;]@_XY?L4^!_$MO\:]'%A+>E&CRH VJ6)Z'T-
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MX/> M,^'WAX@6FFP)$@]0J@?TH ZO!)R0/:EH  &!10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 -DR5P#C/?TJEK>B:5K]C)I.KVRS6\\>R>-Q
ME77T-7GQMPV.>QK!\?\ CCPW\,_"-_XV\8:@MOIUA#ON7D8 (N0,\_6@#\\?
MV_\ _@WC_9__ &CUU;Q]\,($TKQ+<?-!'%$JIN]=Q.!^5?EY^T-_P;I?MK?
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M/[,/P)\9^*!XS\4?#O3[S5!\RW<T(W YS7::7I.FZ)I\>F:;91P01(%2*)<
M#TKG-1^-_P +-+\4)X+U3Q=9QZD1C[-+, V<^E=.EU:3Q)):2JZR<*R'B@:T
M/YL/^#FK$O[=TQ;Y0=-M0/\ OT:^NO\ @U PO@#Q1% /NW$6YC_US:OD/_@Y
MH!_X;SF+MNV:;:G'_;(U]>?\&H(V^ _$YW#Y[B/<!V_=M0*;V/V'\22>'XM
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M (+X>6G_  4;\;%8<*;^4[".!\L=?IY_P:I2LO[,VN3-)D?VHY*^@VKTH$?
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M7! Z>@K^K_\ X)BW]II'[ W@*\FR8X?#GFN6R<!6<U_*%\07%M\<=3$"8/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ31!N",<9%?F[^V+_P &W/[-?QCTFZU;X/0G1=4N)GD+;F*[C[<#K0,OVO\
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M%M _;H_9XU+X?W5HO]KPPNVE2%<[7.!V&>@K^:?]JC_@G-^U-^QQ\27TG7O
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M @P-V!N_6J?P)_9J^$O[/'@^'PC\*_"=M86T7!=(5\QAQU;&3TKOG5Q'\JX
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M<<<9->2_M1?\'+O[2WQD\+:I\//!.C+I%M<!E@O[:%4D P1]Y6SWKVWXM?\
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MHQ&2.*\$_9._X)6_LH_LC7!U7X?>!8#?L/WEQ=*)><8R-P..E?2L4*QPB&)
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M@(J]!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@8'09I%!!W.H7'H:>54G)%!52<D<T -"H5.T8SU--9#&H"N< ]/6I2 1@BC
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M()^@H0?Q G!Z BG8'I10 @#9Y/%*0>W6BB@!#A3NYIDB\A@NXD]^U248'3%
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M T@,-N,\<YH1F (=5'H :=M7.<4%%)W%1F@!$.[GD<=*=1CG-% !0,8XHHH
M0\')'&.M .>IQZ9I< ]12%0>HH 0*PR';Z4;<C )!]<4[ /:B@")2K,2K$8Z
MY'6GG)/(&/7-.(##!&:3:,;<<4 (,*0JTCMM;<PX IX 7@"@@$8(H 9&"5W;
ML@\C/:AF"N V3NZ#'2GX'I10 QU#*?-7('3%-58RHPF!VJ6B@!KJQP$; '6C
M(=BOIT-.P/2C ]* $(W#!XH / #=*6@  Y ZT -QERV3],4UB'<*4&",C)J2
MD*J6#$<CH: & _+B0=#VI68$[2I]B!3MH]*6@!N"."Y/X4ZC SG%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% #""7(''O2#<>-ZD_2I**!-7(P"IS)M_*E<YYZT^B@$K!1110,**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** # /44TKG[N,]^*=10 S"%L;N?:DP
M5;@ _05)@9SBB@!H55(;)&>QIU%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
>444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" *V!=P# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBBI;L 444@)'WJ:=T M% Z4$@=:8KA13/F_O4Y3D=:6H]Q:*
M**8!113=S9P12<DMP'444470KA1113&%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HI"P%(Y7')Z4FTMP'9'K1D>M1C:1G/Z4$@=Z+I*XKHDHIOF>U 3/(:
MA-,8ZD8D#B@# QFAONFF)ZD9;;2^>@7+4V1"0"3D;37G7[3'QQT3]GKX/:M\
M1-5GB4V5H\L<3R8+L!G ITJ-3$XB-.*W"G!N?*C9^)/QN^'/PJT^34?&WB:W
ML5C0MMED )KXM^(__!??]F[P5XKNO#%IIDM^;9]IFBN  ?S6ORV_;'_;F^+O
M[5'CZ^U3Q%X@GM]/\TKI]K%,0 H) Z8[5X-<7#S2F21B[G[SMU-?J&5<$X>=
M+GKN_D>W1P":NS]J(O\ @XC_ &>I)VBD\&W2*#CS#=J<?^.U]0_LR?\ !0'X
M#?M)Z#;WWA?Q-!!=3XQ:33?-D_@*_FT2;!R0/RKH_AY\7?'/PMU^#Q#X0UZX
MM)X6!A,<I W#VKKQG N E1YJ3L.>!A;0_J<AN(KM0T;#IE2&X-6$/RX)YKX2
M_P""/_\ P4(N?VG_  2W@KQ_J,?]MZ7&-TDL@!D7.U<9QGH:^Z8N.=V1V-?E
M>98&KEF-]C)?,\FM3]G.Q+32^#TI2<KD5%.Y(V;,C'S<UR.3YK(R6I(9!C)K
M!\6^//"?@;3VU;Q+K,%K GWI)' Q7 ?M7_M3> _V8_A]=>*?$VKQ).L1^RVP
M<%F;'IG/>OQ3_:P_X*%_&O\ :(\0ZA&?%$]MI,]P"EM&^/E!_ U]1D?#5;.7
MSO2*.+$8J-)V/V#^)W_!2/\ 9F^'4 D/CNTO7)Y2-L8/Y5E_#3_@J+^S+\0[
MQK.7QA;V0Z9D?W^E?@E>:K?7J.U[>SLH;:N9F;G\Z9;ZAJ-M<(ME>2XXWD2D
M5]W'P\PSH_'J<WU[R/Z8? /Q=^'?Q'@^U^"/%=M?1+U,<G/ZUU(D!&0/UK^<
MCX!?MB_&;X :RDO@OQ;<"W656FMY)<A@#DCG-?LW^P#_ ,% O _[6O@>"W:[
MCM==MXP+BS=\%\ DD9ZU\7GO"M?)_>@^:)TT,5&IH?3JMN.,4M5XF+-N#;E8
M9!]/:I4!SFODH\UM3MZ#Z"0.34;-W)IQ(;&3]:E3BW8+,<"",YHR/44P@;>&
MIK,J+EFIN23U%[SV)<CUI"P'4U&K(V"&/TI>,^E4FF-*74D!!Y%%-#!> *#M
M?O@U/-9ZBNF.HHHJAA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%!.!F@<C- !D9QFC(SC-1G .*0X7YJ5XIZA=$I('4T5
M$CJW4XIZ@GHU%T]A)W5QU%%%,7,%%%%!04444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 QQS369,
ME-XSW%#$F1LG  YKSW]H'X]>!/V??A]>?$'QSK,-I:6T9,;ROCS&P2%S[XIT
MJ,\3448ET:<J\N6)WQDB7J_:JK:_HT=S]D:_C\S^YO&?RK\-OVO?^"[GQL\=
M^+I[/X(,UAI]M.4$R_QJ,C.5/TKY\D_X*D_M=RZ^-?M_B-<&3 W*TSD9_.OJ
M\/P?BJM/FD?0X?AJK4C=G]+$=S!)]V0>]/(]Z_"W]B'_ (+E?%_P7\1([#X]
MZLNH:1>SI%)(#@PYPH.6/'7-?M-\(OBOX/\ B]X*LO&?@K5X[W3[V)9()HGW
M94^]>/F.2XC+W[ZT/,QN65L&]3KE?/4TUG;!V_E0"#T-&#G&*\A.\7<\Y;#2
MX$>XDC'85^4?_!?K]I[2GL+/X,Z)J]Q#=K*)+J./&&7D%37ZNR*%4\9P,X%?
M@M_P7.TG78?VMI]4FL'6U>)]LC+P3O-?5<(TJ=7-8*9VY?&/M-3XEE5Y9'N'
M(DE5?W9?M2(/X@, ]O?O2R.\4@WQX#>U!C$;$!LU^[SA3I3M'8^C:22L!.*8
M0&F0RH&4'Y%(Z'UI]-E5R%=2  W)I>ZX)#A9[GOW_!.3XL:E\+/VG?#FHIKL
MEC:27X6_V-A)$P< Y]Z_HT\&:U:>(O#5EJ]A*)(IK9&5P<Y^45_+O\'M"UO7
M/B'I&G^'4EDFN+Q5BV<G<#DU_2S^RMINJZ-\"] T_6%<7$=B@D#]>@K\FX^H
M485XSCN>'F*BG='HAST/:J.O:G%H^F3ZG=$B&"(N^WK5Y<,?FKD/CQK0\/\
MPKUJ_P!A8I9,1^E?GV&@JF)BN[/'E?E9^)'_  5+_:K?]H+X[7]OI.H7']E6
M+"W2TDX4.F48X^HKY3<LTF9($)'?FNK^-UZNH_$[7;F"/!;5)R?QD:N5^M?T
MIDF7X?!Y?#E70^<K3E*H[AC9*8X&+;OF._H#1'D%G#E)!Z=#117I\[3,KL)(
MPPR409^\X/->L_L8_'2_^ _QVT/QQ9:K/!;K,L5XL?!=&=0<_@#7DKXV\G'O
M5SPTL(UJ %_NR ]?>N/,J%'%81P:NRZ4Y*HC^E_X1_$/1OBGX#L/'&A?\>NH
M0++%QV(KIT.#BO!O^"<MZ+W]D[PJ0<[=-B'Z&O>!TYK^:<?35''2IK9-GTM*
M3<-0D^3I33(BC+./:FW(4Q'>Y4#N#7SA^VQ^W3X*_9ET1].BO8[C6)4(BM5<
M;D[9P?3BIP& Q68XE4*,+LY,?CZ6 H\\WH?0>O\ B30_#=B=1US4X;6%>LDS
MA5_,URC?M&_!49C;XBZ/E3SF\7_&OQF^./\ P4#^.WQ?-W877B*Y@M99&,<4
M4A4!3[ UX^/'_C62,[_$5YN)R3YQK]0P/AI4KT4\54L_)'P^,XZIQ3]@M3^@
M[PS\5OAUXLG^S^'/%>GWDF/N6UPK']*Z(3))PN!7\^7PV_:/^+GPMU?^V?#'
MC2Z6<_\ +-IV(_G7W5^P_P#\%8=4U;4[7P-\:+B..29U5;N0@>V<DD]Z\?.O
M#_'9?!SH^]%'7EO&-+&24*FC9^DP9!A<C..E.5P>0!^ K.T36=,\1Z;#JVEW
M*RP31!XIT/#J>E:"X"X%? 3]Q\L]S[F$J<J7-$DHI 0>AI:904444 %%&0>A
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD9L#@T!P>M "Y'K11@
M>E% #6/& :%X'/%*P5?F-,)SS0!$S,)<9^E9.M>//#?AR3R=6U&*$]A(X&:3
MQYXD'ACP[<ZTPR8HF*_D:^"OC'\<?$OCOQ"]S]M,<<9(50:]?*LHEF5W+8_%
MO%KQ8POAG@8N,>>K+:/0^Z;?XJ> [Z00V^OVS.QP%$HSFNAMKR">,26YR&'!
MK\R-.\?>(K:ZC:+4VCE1MR'<>:^QOV2OC7?_ ! T]M$U3)FM4&7/?M_2NS,,
M@> P_M(GQ_AA](+#\>9DLOQ-/V=1[)'O:G(ZTM1Q'.#4F1ZU\X?TK'6P4444
M&@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9FJNHVL5S:O#<1[D(PRXZBO!H3=.O%]F<<[\NA_-+\?-+?3/BQKUH 4/]K7
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 $9&*:""-I'2G$X&:
M80?O>M3=<U@(IY&&5C'..,U\)_\ !<?]I?Q7\"_V>1I/A>1EFUMI+:5XVP5
M0-D&ONZ4*4);T[=Z^"_^"X/[+OQ'_:"^!=M>^ (O,&BS27,\(;YG!0+@#!)Y
MKW.'E2>9P]KM<]?(%2691=78_!_Q!XAO=6U&2^U.\FN&E8LYGE9\$\]ZV?A;
M\1_%?PU\4Z?XD\-:M<6\MI<H\+1S,%8!@<;0?:L?7- U31[^?3KZ*6">"4I+
M#,FW!!P>M;_PB^%?BSXI^.[#P5X/L)+JZO9U2,;3M0%@,Y ..M?O&)_L_P#L
M_P!ZW+8_:\9/+Y8*RMRV/Z/_ /@GO\6=>^,O[-WAWQEXA8FZGL8S*Q[DKG->
M\';CCK7A/_!/OX.^)O@=^SGH'@/Q:BK>6=E&LH5LC(7%>[#!Y]J_GS-%#Z]-
MTOAN?A>92I_79<FUQ%B)')XI#;MG(:I$^Z*6O.G%3W.%^]N0M8Q._G'._&,Y
MH:T#9!;Y2!Q4U%-*RL%W:Q#]E!8,3D@8I1;XX+< Y&*EHI.*9/*A-O(.>E*1
MFBBG;2Q0A&1C-($P<YIU%-*R 0C(Q0J[>]+12Y5:P!1110E8 (R,9I%7;WI:
M*8!111222#<,<YS2!<9YZTM%,!AB(7"M@^II1&.">H[TZBBR 1EW?TH P,4M
M%)12=Q60FWD\]:88,L26X(QBI**:T&97B70+37-(FTC4(EDAGB9'#+D<C'2O
MR6_X*!_\$[/'GP^\7:C\0/ ^DM>:9=SF5UA7[H^GT!K]>;@9X/0]:S=7\.:=
MKEG+8:Q;)<6\@PT<BYX]*]WA_/,7D>(YH?"^A\]G>48?-:?*X^\?SG:EIM[I
M5V;.]M9(I ?]7(A4K^=5Y 8\;@.?0U^TWQJ_X)4_L]_&+7V\2R6_]G2&/;LM
M[<$$YSGEJ\(\5?\ !$#1%UH?V!XBD^RD]61 0/SK]CP/B%D^(I*-5\K/SC$\
M'9E2G[NQ^:*PRRG]VH*C[YSR/P[UZ-\"?V9?B?\ '/6[?3?"/ARXDBFD >X:
M,@*#WYK]'O!'_!%+X*6%O#-XBU.6:Y#J\G[A2&P?9J^LOA3\!_A]\']#@T3P
MAH-O;+#%L$B1X)KR<Z\1<-&BZ>$U?<[<KX-Q$ZRGB%H<'^Q'^ROIG[-7PQM-
M ?9+J$B![N81X.2!E?S%>X"(I'@'-*B+&H4K^-.WKZ5^.8O&5L?B77J.[9^H
MX7!TL'AU2IJR*6H[TLI& SB-L?E7Y$_MZWLDWQZUM9Q@F]<D8]Q7Z^W6# X(
MS\IP/PK\F/\ @HKX<UK2?CYJNJ7FF%;:ZG<Q2$'G)K](\+*D89ZT]VC\2\<L
M-4J\/0<-;,^=B0>@Q0,@8-*XVFDZU_1=7FE)J2U/Y$<'&I>6BV"D=@%)'7''
M%+1MW?+NQ6V(YH487?R%2E352[E>Q)9Q![J'*DX.1SCG%?II_P $HYIC\)YT
M,!"K)\I+YS\QK\S=.$C7496W,C*^,"OU _X)>>']9T'X0F/4],>WWN60NI&X
M%B>]?F'BI*C')G%R]YVT/V'P4IS_ -:?:Q5X]SZL0 KS^-,F/E'(8$8XXZ'U
MI4;"C?WI+T,8\1X'L:_FRG#OL?V95D_9<ZW/B'_@I)\5[&_NK3P=97+B:WD9
MI@K$9!7C^5?',\OG.S29R>X.*]V_;[5X_C=J#^6RAK6(1L1QGG->#ON!^<Y/
MKFOZ?X(PM&GD$)4T?YC^,.98G,>-Z_M7\,FA!E42->BC!R>M(REY SGY1T X
MI:,^E?6>_P#RGY>VO;KW=!RLJIMP?J37H_[-7C1/"'Q5TO59KQHD=]LI#$ Y
M(%>;5J>#[:ZO-;M4MXF8F=/+"CG[PKSLUH4L1@9TYK=,]SA[&8C+N(*&)H[J
M2_,_8;PQK5KK>BV^I6LH>.6,,A'<5IAQMX6N#_9W@O;?X4Z+#>H0ZV"APW7/
M-=PDV7VD5_)F-A&CBI06Z9_JYDV+EBLJI59[N*_(<WS+D\>U>4?M1?"N/XF^
M!)K=(R98UW1_49->L,#U#5!<6ZW$;02*"K#!!J\)B983%1JQZ'-Q%DN'X@R>
MK@*VTTT?DSXS\+7WAG69M)O[=DGA8KM/<>M8K;4F$,C8SW S7WW^T9^QKIOQ
M!DEU[P\5CO7)W8 &17S)XT_9&^*7A&XVQ: DJDX#PN6/Y 5^T93Q1@,5AU&;
MLS_-_C;P8XGX9S.HJ-%U*4GI8\?VL& =/D)X<'-=W\#O VM^+_&-O96&GM,O
MVA7)V\8!&:[3P'^Q=\3_ !&L=S<:<ELK-\P:3EAGN"*^O?V>_P!G'P]\)-$0
MF!9+M@/-E91D'%<N?<486CA'2I.[9Z_A?X(<0Y[G%.MCJ;I4X-/7J=S\/-%&
M@^&+.R, C,<*JR#L<5T"Q!I/,+<]JCBCB3Y8R<?2I5*G@5^.3J.K4E+N?Z.9
M?A:> P4*%+:*2^X<$8C ;\:548=6I4SCFEK.R6AU))V8P*V>E.V\YX_*EHHL
M4%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@!),[>*: 67'I3FQCFD!1>AHLKW)]ZXUQM&< GM5+5M%M-:M)+*
M^@62*5=KQN.&'H:OG:W -)MQU:DIU(3O$N,IPE='QA\=O^"-/[-'Q8UN7Q##
MX>CM+JXD+RF*)0"<YKL/V8?^"7G[.G[..H1^(M \*V\VIQ+\L\T*Y4^H(^E?
M3[[6((7)]:9R[$%=IKTZF>9E5PZHN;LCTIYQC94?9\SL,M(E2,*%.1P<U,1M
M&/6D3:O&<FE W'<>E>;S2?Q'F.[ES2%0]J=2#'44M 7N%%%% !1110 4444
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MGX3>*?"VL>%=1DTG6K1H[B&9DDC*X(Q68RB-RC.IR/EQV^M?JW^TO_P3_P#
M7QFN9->TR 6-[R=R<!VY[**^./%7_!-?X[Z*99[;1#+"LCA2(>2H/!Z^E?T?
MDGB)E.88>,<1)1G;J?Q]Q1X6\09-C9_5X.I!N^FI\U#KPP/TIPM6ED0#'WN
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M[']*4* ,4M% ;@!@8%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% "%0W6@* ,"EHH"PWR_>G8HHI60 0#U%)L7
MTI:*8";%]*-HQC%+10!&(=IR!^M!B)QD=/>I**=V1RZ6()( 2"5Z'(%1O:12
ML1+&#GJ",U;HP/2A-IW0G3B]T9\.A:9!,9HK.-6/=4 JTL*D;0HQCL*FHIRG
M*>[%2H4:/P12(_)X"[>!TI1$"<L*?14WTL:C5B5<\=:'3<<@4ZBBUA)66A&8
M0?X:IZKHUAJD)MK^V216_A= :T*1FP.#1&3IM..AG5HTJ]-TYJZ?0\C\>_LD
M_"?Q[=_;M5T)!+@@-'\O7Z5@Z/\ L(?!72;Q+M-'+E#D!W)KW<_,/F4?A2*,
M'E1CM7L4\\S2G2]G&K)+U/CZW '"];$>VEA(.7>QB>'?A_X=\,V\<>DZ5#'Y
M:A5*Q@' K:$,8.=O6I X'!'TQ2A0#D"O*J5:E:3<W<^JPF!PN!HJE0@HKLAI
M@0C%*8E*[:=14=;G4DH[#5C"C;VI=BYSBEHH&]1NP;MU'EKG-.HH!J^X8'Y4
M$ \&BBDTF U8U4Y%*$ .:6BF#5PHHHH **** "BBB@ H) &2:#P,U4U34[+2
MK&34-2N4BAB7<\CL  /K1JP+#,X;;V/>B.3+;"V<5YA=?MA_LYV5S);W'Q6T
MA)(FVR1-?Q@@_P#?5-_X;'_9J&"/BYH>&&<?VE%_\56BHU7'8GF1ZFQX^4BF
M%V!SG\/6O,/^&R/V:_\ HK&A_P#@QB_^*II_;%_9O+!T^+&@Y'KJ<?\ \51&
MA5ML',CU'SL+F08STI^[&03FN.\ ?';X5_%2XGL_ ?C&PU.:WSYB6ERDF.,_
MPDUUD3%T$AS\W.#VK*THRLQIW)-Q()I5)(R:%48Y[TH&.!3&%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(IW
M#.*6DQM4@&DM@ -NY!QBDW9;KQ4<CD-Y:G: ,LWI7G_B;]J+X%^#]:?0_$?Q
M*TVUN8^'BFO(U_/)HA&4F%ST;(]11D>HKRS_ (;(_9K_ .BL:'_X,8O_ (J@
M_MD_LU#K\6=#_P#!C%_\56GLJO8GF1ZGD>HIKM@9!KRX_MB_LTJN_P#X6SH?
M_@QB_P#BJO\ A/\ :=^!_CO64\/^$_B+I=Y=R?<A@O8V)_ &CV51;H3DK'?B
M8L"Z\@=1BG*['!]>U,5I"^Y<8 ^;!IR[<AE'4YK)7YF6B2BBBGU ****8!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M _&_Q@/^F<O_ *(6OZ+$Z?C7R>/@J==I'92=XB@@C(HHX H!R,UR&G4****
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M 4444 %%%% !1110 '@&F!B2.:>W0_2F+U'UH?PLG[16UG_CQG_ZYFOX^/\
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M5,WWQ4%HP58U)ZH/Y5,Q!.0:^-DTI'8MA]%,WMZT;V]:.:(Q]%,WMZTOF*,
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M .@&,'\J1BC*04/O7\N(_P"#KW]OPXQI>G9(SC[5-7L?[#7_  <7_P#!1/\
M:8_:/\,?#./P9'>6-]JD2:B;229S'$6P2:BIEM6C"XXUN8_HK'EGD= ...E.
MC4(NT-FLSPI>7=_X?LM0U&(I-/9QR3)C[KE03^M::$$GBO-CS<UF;[CJ**"<
M5;=@"F2$GY1^)IWF(20&R1U ICNA;&\ GI4MSMH&@%XT&T#/KBF&Y0-]Y@,X
MQBO)/VBOVV/V>_V8_#M_J7Q-^)6E6-W8P/*=.FNU69PHYVJ3S7Y)_MQ?\'9'
M@O3O#USH7[+^@S2ZK#(RI<7JE$; X.5;UKHH82K6>J,Y32/V[UGQ1X7\/1[_
M !!XALK)6Z-=W21C_P >(KC?B%^U#\ _AAH,OB7Q3\5M$6VB4EA%JD#G'T#U
M_)_^UW_P7?\ VYOVM+.*TU;QQ/H,<?7^R[M^1@#^*OF/Q'^U+^TAXPLFTOQ/
M\9-:O+9N&BFN 0?TKTX9.W9R,O;6/ZP?$/\ P< _\$Y?#.IRZ7?_ !3<O$Q#
M&*UW#]'JA_Q$3_\ !-#_ **G<_\ @O/_ ,57\B$ZM/,T\ZB9W.6DDZFH_LR'
M@P+78LGII"]LC^O,_P#!Q-_P30[_ !2N?_!>?_BJ%_X.)O\ @F>>5^*EU_X+
MS_\ %5_(8+2'/-NE MHQTMTJ?['@]@]NC^PKP9_P7T_X)S>.]=A\/Z/\5I!/
M*P"F>UV+^9?%?3_A']HGX(>.-)AU_1?B=H+03(&C9]8@5L$9Z;_>OX7;.YN]
M-G%WIQ$,J_<D0\J?6O0- _:Q_:8\.6J:?I'QMUVU@C4"..&Y  Q^%95<HLM!
MJLC^XK3M>T/7+8:AHFJ6M[&.CVUPLB_FI-6DG5FW;V _NE:_D>_9-_X.&/V[
MOV8/#J>$K3Q8^MP;LM)J5V^0 <_PU^HO[$7_  =:?!GQIX?T?PM^T1I4]GKE
MU+''-=1)F($G!)9F]Q7GU<LJT]4BE6N?M"LF0./K3B0.37FWP._:B^!_[0>F
MQZG\*OB'INK^9;B:2*TNE=H@>S =#7HVX,0H;MTKA:<79FR:DAX(/(HIJNH
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M='_$1+_P30_Z*E<_^ !_^*K^0XVT1^80+GN*3[.G_/NE;O)Z2>A/MS^O(?\
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M/^"G?[9OQR\=W7CK5?C1K&G27/(M[.[^5>OJ/>O&_&WQ;^*GQ'D\WQ[X[O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA!XKM]3LY%#,()=S(<9P3@>M?P]Q;HE^5OF'0^E?7W_!+#_@K'\:_P#@GO\
M%VPU*T\17%YX9EN%&I:;+(658\Y+#)('3' KQ<;@.97@C2G4=]3^Q9F5\R#[
MA &1U%3(<' [UXK^P]^V1\)?VU/@O8?%3X9:Y%<1W4(^U6PDRT4@"[@1UZG%
M>SQR!F//3VKY^47"5F=5[K0D8C'-5-7TVRU;39M.O$\R.9-LB'H15IF+*"!U
MIDAVJQ'9>.*S22DF79-:G\GG_!QC^Q5IW[+?[8]]J7@C0Y(=$U@K=/<JOR>;
M(ID<9X[M7YVXD[./RK^J/_@Y3_8=U+]IS]D*X\7>"=)A_M+0D>>XG\I=[KA1
MC/7C!K^5Z]M6TZ]EL+@D-#*T;$CN#@U];E]?VM.R."I%Q8TB3'+#\J8=YZXX
MH.X,1MX!P#ZT*H6O0?,GN9.Y9TC5M0T;5+?6-/NS#-;3+)%*I(((.1_*OZO/
M^#<[]L*W_:/_ &+])T7Q1XT34/$FDVZ0W=L9277ACT/MCO7\G2A8U(9NI]*_
M4;_@V'_;:T+]FC]JQO GBF[F>/Q.YC@A:5MJLR+&..G5J\_,:/M*/F:TI69_
M4K'D #J,<&@$EB":ALY5D3SHVW*_(]JG7!^;%?)*T'9G<G="T4 @]#13BFEJ
M,****8!11D9Q2$X[4 +2,VT4F\+D=^N*@N[N&&W:[E?$:*2Q/;'6DI*3L@>A
M\)_\' ?[:5_^Q_\ L7:QJ.FV\5Q<ZT@LHX=H+;)=T3'D]MU?R0:SJ\FKZW<:
MQ(</<2DF,]LU^K'_  =0?M6W?Q3_ &K8/AIX2\;F[T334D$]G%(2@<%2,C..
MN:_)\!&4RQ_>SSFOJ\JA&G2]]:G)6DGL.(D[$4C@[?WC@#Z4E(S.HR@!/O7I
MQD^;8YH^8\!W*D EBA8LO8"OW!_X-,OV-?%EYXSU/]I'7?#1N-&-N8+:ZN(=
MRK(=K#!/?%?BU\*_!5S\1OB/H'@6WMI9SJ>JV]O*(5)(1Y55CQ[&O['/^"3G
M['?A3]CC]D7P_P" O"S';>V<=S<AP=P?;M[_ $KR,SQ*A'E>YO2@?3L2B-1L
M7C:!M':GIWIL<93 0X7T-/8[1P,U\NFVSL6B%J*8_/G).WD*IY-.,V",+D$=
M:YCXN?%3P-\(/ ]]X[^(.NPZ?IME TEQ-*X'RCKCWH@O:3Y4,TO%?B[PYX(T
M6?Q)XHU2&RM;>,O-+*V H]Z_'C_@L)_P<D>!O@_I=Q\(?V3-7AU?6I2R2ZG;
M2*ZQ,I]\$?\ UJ^'?^"X'_!>WXB?M6>-;KX+_L^:_/I?A/3YWAEN[:0AKDC*
M-R,'&5!_&ORKU#5K[5[UKW4[R6XE<DM++(6))[Y-?0X/+97O41A4JJUD>G?M
M'?MH?M&?M5^+)/&/Q6\?W]UJ)5EFA6Y<)M)R>"37E*B<DEH3DG[S\TJJ7 $C
M'(7&1QF@11GE]VP<%MW2O9ITZ5):(YW)O<:VY#FX/'H*=UY%(C1 G83@="1U
MH+%0"ZXS]WWK9WD0Q:*#E1N88'>FARYQ$N:=M";7'44I21>2A_"FAU9=P/X$
M5"DU*P[,6BE49(+'"]V]*1_D&_\ A/"GU-6Y.VHK,-SH"R8]\TJ(\3"1 X,9
MRCH<$&FG:S[221CD8Q0JJIR,_G6;?,K-:#6A[?\ LM_\%#?VI/V0=?.O_";X
MB7UNDRA)[>XN'92N<] P':OZ#O\ @D7_ ,'%WP4_:>\,6'P\_:%UN#P]XCC1
M(([F]F55NG&%X"Y/8GGUK^8(JI<,I(YZ$YXJ[HFOZUX<U./5]#U.>UN(&#02
M02LI5O7@UP8C+J-7X3>,[']W^E:SI&OZ3%K&EWRSVMPH:*:)OE8'IBKA1?EA
MP>!D-7\[W_!!'_@X"UKP#JNG?LR_M3>(S<:=<,(=,U.Y?)4G@ DY/4CJ:_H3
M\+>(=$\5Z%;^(/#VI17=I<Q!H+B*0,KJ>^17S>(P]3#RM)'3&:DC3'0<T4@(
MZ ]* P)Q7,I)[%BT444P&K]\UY)^W!_R:_XO_P"P5)_Z :];7[YKR3]N#_DU
M_P 7_P#8*D_] -:T?XT?5$R^$_BP^.?_ "6'7_\ K_E_G7')]T5V/QS_ .2P
MZ_\ ]?\ +_.N.3[HK[6E_"1Y\]QR=?PJ*7_6_C4J=?PJ*7_6_C54]Q(_;+_@
MS8_Y+9XR_P!R3_TG6OZ+8_N#Z5_.E_P9L?\ );/&7^Y)_P"DZU_1;']P?2OD
M<S_WEG=1^$6BBDR,XK@6QIU%HI"<=J21W4J%3()P3GI0VEN,=4$<*C><9!((
M3TI_GJR%E&0*\"_;W_;H^&'[#GP8U#XC^.M9B298C]@M6DPTCD$#_P >Q50A
M.I)**(E)1.P_:D_:H^%'[)OPSO\ XF?%/Q);65M:6[/&D\FUI" 3M''M7\ZW
M_!3_ /X.6?C?^T?)J'P[^ <LN@Z&MU+ ]W"P#31#@$,C#V/(KY<_X*>_\%8?
MCW^W]\3+Z?5?$=S9^'A*S6VF0S%5VYR,[2 >I[5\@%GW!U;D>O>OI,%EJ4>:
M:.:54T_%GC?QCXZU&35/%NOWVI/+*SH]Q<%\L3ENIK+4/GY80I]2*1B0H+G.
M#QCWI0BJ^PJ?,Z[=U>M",::Y4B&VU<3>"^T@[L<FG4&1F0D8(7J,4BAV42!?
ME_B.>E-II:F6KV%HI"3G*(S+V(4T9;_GD_\ WP:A3CW&HR2%HI QR<Q/P,YV
M&C),0D [_,IX(%4FF'*Q<=Z-X7KBE"9&]GPI'''6FDCY=HR67(&*IR;1.J9)
M!=75M<)/82%)U/R21G!6OJ[]@'_@K=^T]^PYXUT_5M!\<76H:#;SYOM,GF9]
MRYZ ,V.M?)A656#JP5U/!J1YI&D\U0-Q&&&.#6$Z5.:U1M&4D?UQ_P#!,+_@
MN5^S3^WWI]MX5_X2"VTOQ4\0,NDSSKO)"\X"C'Z]Z^[XI).-AR@XQWK^%/X.
M?&+XA_ WXA:?\0OAUXAGL-3L;A)$,$I4$!@2IP1G.,5_3O\ \$.?^"X7@3]M
MCP-8?"/XM:U#8>-M/MUCD6:0#[20.2.W4XKY_'8"5)<U-:&\)W/T[5LG!I=P
MSMJ%9@W*8(QE2#D&I%;+].>]>-#F>YT+8?1115@%%%(<=_PH 6FR#<""<#')
MIK3,JYV<YZ9KD/C=\7_"/P5^'>I?$7QMJ:6MAIELTLSR-CIU^M%.#J3LB6TD
M)\8?C1\._@5X/NO&?Q*\2VVG:?:1&1I+F3&<>^#7\^?_  6$_P"#D[XA_$?Q
MG>?"G]D'7&L=(L_,@GU6*0'SP>#AE(/J.:^:?^"RO_!9/XP?ML?%W4_"/A7Q
M/<V'A/3[J2"&"VE*^<JEDSE2.N :_/KS975C*Y9W;<78Y)Y[U]#@\ X2O-'-
M4JI*R-WQ_P#$[Q]\4-:G\1>-/$]]J5Q<R>;<>?<,P+?B:PAY:_O<_12>E)+F
M5OF/ Z <4F(HXB'.#_#[U[,(0@M$8-MH49;]Y(<#M10 ^ A7(/0TTR *6(/!
MQ@"J<NY(ZBEVY 93D%<YI%^<@+TII7 **$#N6*KPO4YI&(7D_I3Y9="6G<6B
ME1'D_P!6,_C2$,,\=.M-I-%*X8+ H!R:=#++#*MY"TJ3QGY)(FP14:,77/3G
MFG?*O"# [YK-\MK-#3:9]-?L3?\ !5+]JW]BCQ?IVK^"?'5W/I<5ZLUYIMQ,
M[B5>Z@%@*_I"_P""7W_!=7]FS]N_PW8>&]8\16^D>+2BQS:5<3KO=P ,A5!'
M)!/6OY(6B3(,98<\Y-=)\+/BOX^^#?C"T\;> /$5Q87UG,LD<D$K+DCUP1FO
M-Q&7TJVQO&I)']V:7*21JRJ"CJ"''0CM4B@!<$Y7M7Y>?\$ _P#@LE8_MO>
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^9W]LG_@U0^/?P0\):E\0_A/KQUY8YP+;2T>,G:<]D!;C%?EM\9/@/\ %SX
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ME&VH\<#%-E^[]_:?44ZH97&<,O7O7GRDXK0U>Q#?WMO:6S75U=I#&HW,\C
M =22:_GO_P"#H#_@J;=^)?%B_LM?!CQPTFF0 KK)LY@09?F5A\I.1TK]+?\
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M5<#T%+L'J:XI8VNY;FKIH_/&X_X-J_\ @FJJ;&^%]MAN.+=NO_?=?'W[9/\
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M1_P03_;*U#]KG]BC1M5U=%2YTF'[*RG&[;'B,=/]VOY#HU4 AVPQ.!7[0?\
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M^+Q!_P!?1_FU>KE>Z,\1\)\:I]\_44[^/\::GWS]13OX_P :^G.%;#'^X/\
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M_0T0_P#@0G^-'_$2[^PO_P!#1#_X$)_C1]3Q/8.>)^D>\>AI&92,GM7YN_\
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M1P70(R""K$_RKR8+O.T=Z^G_ /@E%X[^"OPP_:FT3XH?&'5([:UT*[CF19'
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M9@G- SL->8G=7-ALTR(#E^G45^/'_!UA^V_IWPM^!=G^S5;V[M=^(T%RQCD
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M&-D1D)P6ZBBOH'[S.6P8SP1FNZ^!/[-WQ:_:0UN3P[\)?#DE]<0 &6.W5F8
MG&2 #WKA<@<DX]Z_6K_@TNUGX=V?[5NOZ9XUN+(/>:;#'9)<CEY//S@?A6=;
M$/#TVRJ>K/B>3_@E!^VH)"(_A1?DIU_T:3G_ ,=I/^'4G[;/_1)K[_P&D_\
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MAQX&MIA<6OA2TBD4\2)  14RS:4X\MMQJE9F;\$_"R>$?AAH6@B$(;73T1E
MZ'%=;$&#')^E(BI'$(HH]BKT%/3K^%>/*5YFR0ZODW_@LW_R9!XI_P"O7_&O
MK*ODW_@LW_R9!XI_Z]?\:WPW\>(2^$_CH\;?\C?J/_7TU9E:?C;_ )&_4?\
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ME\=Y(T8UY&;U%&CR([:"NCW@*!T%+117SATC5^^:\D_;@_Y-?\7_ /8*D_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&<XKCQF'6*@TC6$K,_N?$K+\Q.1G!/I4VX!>>:_-W_@B]_P7!^%G[=?PTL_
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M?@GJ^JZAKNISZMK,\D]W<2M)//*V2[,<DY_&O<PF7>TCS3V,)U&EH?O_ /\
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MV-M=_P"PI!_Z(K]?/X/PKXW'I^V9VTMA$'&?6G4B?=%+7*MC4****8!1110
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MQD&EPR7T)CVD3%0&R/7BO=438,9)IL,*1*%10% X %/KY"I-U:AVQ5D%%%%
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MC^RM^PYX;L%M_"5CK>OQ$^=JTT"N,CI]]=WK7G5LSITKHUC1N?GS_P $7O\
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M:=B^E&Q?2K56HE9-BY4>+?\ # /[(7_1$M%_\ (O_B:/^& ?V0O^B):+_P"
M$7_Q->T[%]*-B^E/VM7^9BY4>*G_ ()__LALNW_A2NB@$_\ /A%_\37<_"WX
M'_"OX+V4VG_#7PA9Z5#<.'E2U@5-QQC/R@=J['8OI1L7TH=6K)6;8*,5T!0
MH ]*6BBLK).Y04444P"BBB@ HHHH **** "FF-&;<1GBG44 )L7THVKZ=*6B
MDTF GEIZ5F:_X9T3Q%IT^FZQI-M=0S(4ECFA5MP].16I3&0.V\.5P:I-QV%9
M'SU\4_\ @F9^R%\6_#=]H>L?"+2H3?(PFEBM8T;)[@A<U\.^+?\ @TR_8J\0
M:S+J<&JW%NDCLRQK)(0,G/K7ZS/Y3\.F?<"@1Q[?+C!7Z"MX8NO3VDR7!,_!
M/]H[_@T72&:>3X$>)"Z[3Y(E)Y/;[S5\RZK_ ,&G?[>-M>F.RFMWCSP=\?\
M\57]0I1N%= RCOFE*C'R*!GUK:.95UU)]E$_ER'_  :@?M]ODB2WS_=WQ_\
MQ57?#?\ P:<?MTWFIK'K-U!#!N^=MT9X_P"^J_J "E4W!06]Z/*PV[U[53S2
MJ^HG270_"O\ 9X_X-%O!TD"3?'#Q:P8)\PCW?>_X"U>_?#?_ (-3/V*/ OBN
MV\37-W-?K X8PR228./J:_541QJ22G7K08\?+'$I4]>:YYX^M+J-4T>(?#/_
M ()Y?LG_  KTZQL?#WPATE7L0!#.UI&S9&.<E<]J]HL='TRPA6VL;"&%$7"B
M.,# ]!BK,:1@85<4\ #H*Q=6=17;+44AJQJJ!.N!Q2"%%&%&.:?14E  !Q11
M10 4FU<YQ2T4 %%%% "$  D53U?2=-UO3Y=+U:T2>WF7;+$ZY##\:NTFU?2@
M#QJ]_8-_9-U&[-[>?!C1WE))+FQBR2?7Y:B/_!/_ /9"+%O^%)Z-R<G_ $&+
M_P")KVK8OI1L7TK15JJ6DF)Q3/%?^& /V0O^B):-_P" ,7_Q-(?^"?O[(3-N
M_P"%*:*,?].$7_Q->U[%]*-B^E"K55]IBY(G _"O]F_X*?!2\EU#X9^!;'2I
MIL^8]K;HA.1CL!VKO4PXW&EV+Z4H ' J)-R=V-)+8  .!1112&%%%% !33%&
M1C;3J* &B-10(T7D*!3J* (I;:%E8E =W4$9%<3\2_@'\(OBU#%%\0/ >G:H
ML0VH)[1&QDY[J:[IAE2*C$95<Q*.324W3?NDN*;/A']KW_@@)^Q7^U48Y[KP
MC#H\D9W![,;/7C"8KY@\:?\ !HS^RO+H=Q)X.\47"WVT^2&:3&?Q:OV-\M1)
MDQY..M.9#NW%L =JZX8ZO#:1/(NQ_-7\6O\ @TI_:IL-6D?X::S#/:ESMW%
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M(QV.A/X5I"K5ALQ<J/R.U3_@TH_8KN;RXN8?$-S&9G+*H:4A<G/K7S[^T/\
M\&BY@,[? GQ:9$_Y8&4'G_OIJ_?,J"0J$ #KBF$*_P R9'/I6T<;6@[N1G.F
MFM$?R]WW_!IS^WM!>,+.XMWCS\K;H_\ XJOT%_X(!_\ !&;]I;_@G1\8]<\;
M?%]XFL[ZP$481D^]Y@;L?05^P*I^[SC<?>FLF5PT:$$=SWK2ICZE6-FPC3L+
M;JZ1[6;))S4A4$Y(J,;RJ[\*1V4YXJ6O/BTVS4****L HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ (!.2*" >
MHHHH *,#KBBBIY4 C GIB@ C[Q&*6D?[IIV0"X Z"C SFH\GUIZMGBA*P"@
M# %%%%,74****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4UD+9!/%.HH :$8< T;7
M_O?K3J*3:6X#=K#O2E0P^84M%+W6 C!=O(XI-Z^E.(R,4T( <DT<J =U'%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ!;H\LK[ B[F9C@"I#(H7<#D>U9WBK2#KV@7>D&X9!<0E0Z]1F@#\\/VZ/\
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MP*3<,XI:!IW"BFM+&@!=L9Z9I2R@@$CD\4#%HI-RGH>E()48@ ]>E #J*0N
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M9QG\: '44UI8T4,S@ ]#0)DYSD8&>: '4QSB0>A'-.#J<8YSZ4UVVO@=QS0
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MC1K'1+#[3?7U[-&45=P4G*_6N3_:Z_X.'/V2OV:O%A\+Z'?KXG*'83I5RG#
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M '@)TZU]+?%SXA6'PI^&^L?$/5XA-!I%F9Y(TX8@$#O]:_'?_@TSW-HGC")
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MFD:QC"Y_$T"/B;X[?\$*/V)OC4LU_<>#OLEUY3+$\ 10&(X)POK7Y4_M8?\
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MEEO92REB<E@'/3)K]E_^#?;]@_XY?L4^!_$MO\:]'%A+>E&CRH VJ6)Z'T-
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MX/> M,^'WAX@6FFP)$@]0J@?TH ZO!)R0/:EH  &!10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 -DR5P#C/?TJEK>B:5K]C)I.KVRS6\\>R>-Q
ME77T-7GQMPV.>QK!\?\ CCPW\,_"-_XV\8:@MOIUA#ON7D8 (N0,\_6@#\\?
MV_\ _@WC_9__ &CUU;Q]\,($TKQ+<?-!'%$JIN]=Q.!^5?EY^T-_P;I?MK?
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M/[,/P)\9^*!XS\4?#O3[S5!\RW<T(W YS7::7I.FZ)I\>F:;91P01(%2*)<
M#TKG-1^-_P +-+\4)X+U3Q=9QZD1C[-+, V<^E=.EU:3Q)):2JZR<*R'B@:T
M/YL/^#FK$O[=TQ;Y0=-M0/\ OT:^NO\ @U PO@#Q1% /NW$6YC_US:OD/_@Y
MH!_X;SF+MNV:;:G'_;(U]>?\&H(V^ _$YW#Y[B/<!V_=M0*;V/V'\22>'XM
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M (+X>6G_  4;\;%8<*;^4[".!\L=?IY_P:I2LO[,VN3-)D?VHY*^@VKTH$?
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M7! Z>@K^K_\ X)BW]II'[ W@*\FR8X?#GFN6R<!6<U_*%\07%M\<=3$"8/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ31!N",<9%?F[^V+_P &W/[-?QCTFZU;X/0G1=4N)GD+;F*[C[<#K0,OVO\
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M%M _;H_9XU+X?W5HO]KPPNVE2%<[7.!V&>@K^:?]JC_@G-^U-^QQ\27TG7O
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M @P-V!N_6J?P)_9J^$O[/'@^'PC\*_"=M86T7!=(5\QAQU;&3TKOG5Q'\JX
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M<<<9->2_M1?\'+O[2WQD\+:I\//!.C+I%M<!E@O[:%4D P1]Y6SWKVWXM?\
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MHQ&2.*\$_9._X)6_LH_LC7!U7X?>!8#?L/WEQ=*)><8R-P..E?2L4*QPB&)
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M@(J]!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@8'09I%!!W.H7'H:>54G)%!52<D<T -"H5.T8SU--9#&H"N< ]/6I2 1@BC
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M()^@H0?Q G!Z BG8'I10 @#9Y/%*0>W6BB@!#A3NYIDB\A@NXD]^U248'3%
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M T@,-N,\<YH1F (=5'H :=M7.<4%%)W%1F@!$.[GD<=*=1CG-% !0,8XHHH
M0\')'&.M .>IQZ9I< ]12%0>HH 0*PR';Z4;<C )!]<4[ /:B@")2K,2K$8Z
MY'6GG)/(&/7-.(##!&:3:,;<<4 (,*0JTCMM;<PX IX 7@"@@$8(H 9&"5W;
ML@\C/:AF"N V3NZ#'2GX'I10 QU#*?-7('3%-58RHPF!VJ6B@!KJQP$; '6C
M(=BOIT-.P/2C ]* $(W#!XH / #=*6@  Y ZT -QERV3],4UB'<*4&",C)J2
MD*J6#$<CH: & _+B0=#VI68$[2I]B!3MH]*6@!N"."Y/X4ZC SG%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% #""7(''O2#<>-ZD_2I**!-7(P"IS)M_*E<YYZT^B@$K!1110,**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** # /44TKG[N,]^*=10 S"%L;N?:DP
M5;@ _05)@9SBB@!H55(;)&>QIU%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
>444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45537572498160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 03, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb.  03,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Evolent Health, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">32-0454912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1812 N. Moore Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Arlington<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">VA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">389-6000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">22209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock of Evolent Health, Inc., par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EVH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001628908<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MW>I3AN#U"[S^)7CC((#%GEY]W)#/\![Y$E=F$5>D/<K(<X,\*:4%3 T-EHJ
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M SL[Y_MHJ2KG9HW ]/4! SDY*.#6_3&>9/KN;WB\%F<WFC5"SW_,L7T;*ZL
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M;%!+ 0(4 Q0    ( "XX1%H9C%VE[@   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( "XX1%J97)PC$ 8  )PG
M   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ +CA$6N<0HD9C!   /1$  !@              ("!#0@  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( "XX1%J?H!OPL0(  .(,
M   -              "  :8,  !X;"]S='EL97,N>&UL4$L! A0#%     @
M+CA$6I>*NQS     $P(   L              ( !@@\  %]R96QS+RYR96QS
M4$L! A0#%     @ +CA$6JK$(A8S 0  (@(   \              ( !:Q
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( "XX1%HD'INBK0   /@!   :
M              "  <L1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( "XX1%IED'F2&0$  ,\#   3              "  ; 2  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /H3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="evh-20250203.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.evolenthealth.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="evh-20250203.htm">evh-20250203.htm</File>
    <File>evh-20250203.xsd</File>
    <File>evh-20250203_lab.xml</File>
    <File>evh-20250203_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "evh-20250203.htm": {
   "nsprefix": "evh",
   "nsuri": "http://www.evolenthealth.com/20250203",
   "dts": {
    "inline": {
     "local": [
      "evh-20250203.htm"
     ]
    },
    "schema": {
     "local": [
      "evh-20250203.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "evh-20250203_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "evh-20250203_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://www.evolenthealth.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "evh-20250203.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "evh-20250203.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.evolenthealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001628908-25-000010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628908-25-000010-xbrl.zip
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MARF5N2 $. Q&;36EBD?YBD,N!-R '-]]%,LW'K:Q=ZM8[ZM\9 &5VWT8[N\
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M1E"@.5=&2I_/8(%\.N8[L4QJUYD;-9:?E>)6-U0@K.02/10+OGT,O2=IQHF
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MI>OXB+T)J[U+K&Z,Y:)<70^H6S](H789I/,<-,6!KYANJ%S8@/8U-G93+39
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M^\>/(N*UM?8$UMH_!DDP@_^,\TGTR_\#4$L#!!0    ( "XX1%H91M>6B \
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M?B5#/$/><C#X\4PP)'%[\)RJ:0Y<U4JICK XW4AFK.++&8;S .ZP5'!Q230
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ML*0H49#0;>4#<=IX(L!8YE1&4S2#W/[:VE.OOP[J^SK,JCI"C?/'SIRKP[,
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M:'BW>";B.3:<'#R>: _M/]*<'/P/4$L! A0#%     @ +CA$6AD8LGYU40
M\E," !4              ( !     &$R,#(U,C1E>&AI8FET,3 Q+FAT;5!+
M 0(4 Q0    ( "XX1%H91M>6B \  &1"   5              "  :A1  !A
M,C R-3(T97AH:6)I=#DY,2YH=&U02P$"% ,4    "  N.$1:-=\X+%89  "W
MJ@  $               @ %C80  979H+3(P,C4P,C S+FAT;5!+ 0(4 Q0
M   ( "XX1%I7:5Y_8@(   4'   0              "  >=Z  !E=F@M,C R
M-3 R,#,N>'-D4$L! A0#%     @ +CA$6I:7UWF@"@  FUL  !0
M     ( !=WT  &5V:"TR,#(U,#(P,U]L86(N>&UL4$L! A0#%     @ +CA$
M6IK+UMX*!P  &#4  !0              ( !28@  &5V:"TR,#(U,#(P,U]P
<<F4N>&UL4$L%!@     &  8 A@$  (6/      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>evh-20250203_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="evh-20250203.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001628908</identifier>
        </entity>
        <period>
            <startDate>2025-02-03</startDate>
            <endDate>2025-02-03</endDate>
        </period>
    </context>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-22">2025-02-03</dei:DocumentPeriodEndDate>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-23">0001628908</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-24">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-02-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Evolent Health, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-37415</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">32-0454912</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">1812 N. Moore Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Suite 1705</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Arlington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">22209</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">571</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">389-6000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Class A Common Stock of Evolent Health, Inc., par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">EVH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
